Revisions to EPA's Rule on Protections for Subjects in Human Research Involving Pesticides, 5735-5755 [2011-1629]
Download as PDF
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
40 CFR Part 26
[EPA–HQ–OPP–2010–0785; FRL–8862–7]
RIN 2070–AJ76
Revisions to EPA’s Rule on
Protections for Subjects in Human
Research Involving Pesticides
Environmental Protection
Agency (EPA).
ACTION: Proposed rule.
AGENCY:
EPA proposes to amend the
portions of its rules for the protection of
human subjects of research applying to
third parties who conduct or support
research with pesticides involving
intentional exposure of human subjects
and to persons who submit the results
of human research with pesticides to
EPA. The proposed amendments would
broaden the applicability of the rules to
cover human testing with pesticides
submitted to EPA under any regulatory
statute it administers. They would also
disallow participation in third-party
pesticide studies by subjects who
cannot consent for themselves. Finally
the proposed amendments would
identify specific considerations to be
addressed in EPA science and ethics
reviews of proposed and completed
human research with pesticides, drawn
from the recommendations of the
National Academy of Sciences (NAS). In
seeking comments on these proposed
amendments, EPA does not imply that
the current Federal Policy for the
Protection of Human Subjects (the
‘‘Common Rule’’), which governs
research with human subjects
conducted or supported by EPA and
many other Federal departments and
agencies, is inadequate. Indeed, the
amendments proposed here would make
no changes to the Common Rule or
EPA’s codification of the Common Rule.
Rather, EPA is proposing these
amendments to other portions of its
regulation as a result of a settlement
agreement, and is now seeking comment
on these proposed amendments. The
settlement agreement makes clear that
EPA retains full discretion concerning
what amendments are proposed, and
what, if any, amendments are finalized.
Furthermore, no research has been
identified that is outside the scope of
EPA’s current rule, but that would be
within the scope of these proposed
amendments. EPA seeks comments on
the need for and value of the proposed
changes.
DATES: Comments must be received on
or before April 4, 2011.
mstockstill on DSKH9S0YB1PROD with PROPOSALS
SUMMARY:
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPP–2010–0785, by
one of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the on-line
instructions for submitting comments.
• Mail: Office of Pesticide Programs
(OPP) Regulatory Public Docket (7502P),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001.
• Delivery: OPP Regulatory Public
Docket (7502P), Environmental
Protection Agency, Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA. Deliveries
are only accepted during the Docket
Facility’s normal hours of operation
(8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays).
Special arrangements should be made
for deliveries of boxed information. The
Docket Facility telephone number is
(703) 305–5805.
Instructions: Direct your comments to
docket ID number EPA–HQ–OPP–2010–
0785. EPA’s policy is that all comments
received will be included in the docket
without change and may be made
available on-line at https://
www.regulations.gov, including any
personal information provided, unless
the comment includes information
claimed to be Confidential Business
Information (CBI) or other information
whose disclosure is restricted by statute.
Do not submit information that you
consider to be CBI or otherwise
protected through regulations.gov or email. The regulations.gov Web site is an
‘‘anonymous access’’ system, which
means EPA will not know your identity
or contact information unless you
provide it in the body of your comment.
If you send an e-mail comment directly
to EPA without going through
regulations.gov, your e-mail address
will be automatically captured and
included as part of the comment that is
placed in the docket and made available
on the Internet. If you submit an
electronic comment, EPA recommends
that you include your name and other
contact information in the body of your
comment and with any disk or CD–ROM
you submit. If EPA cannot read your
comment due to technical difficulties
and cannot contact you for clarification,
EPA may not be able to consider your
comment. Electronic files should avoid
the use of special characters, any form
of encryption, and be free of any defects
or viruses.
Docket: All documents in the docket
are listed in the docket index available
at https://www.regulations.gov. Although
listed in the index, some information is
not publicly available, e.g., CBI or other
ADDRESSES:
ENVIRONMENTAL PROTECTION
AGENCY
PO 00000
Frm 00017
Fmt 4702
Sfmt 4702
5735
information whose disclosure is
restricted by statute. Certain other
material, such as copyrighted material,
is not placed on the Internet and will be
publicly available only in hard copy
form. Publicly available docket
materials are available either in the
electronic docket at https://
www.regulations.gov, or, if only
available in hard copy, at the OPP
Regulatory Public Docket in Rm. S–
4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA. The
hours of operation of this Docket
Facility are from 8:30 a.m. to 4 p.m.,
Monday through Friday, excluding legal
holidays. The Docket Facility telephone
number is (703) 305–5805.
FOR FURTHER INFORMATION CONTACT:
Kelly Sherman, Immediate Office of the
Director (7501P), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460–0001; telephone
number: (703) 305–8401; fax number:
(703) 308–4776; e-mail address:
sherman.kelly@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you sponsor, conduct,
review, or submit to EPA research with
pesticides involving human subjects.
Potentially affected entities may
include, but are not limited to:
• Pesticide and other agricultural
chemical manufacturers (NAICS code
325320) who sponsor or conduct human
research with pesticides.
• Other entities (NAICS code 541710)
that sponsor or conduct human research
with pesticides, and Institutional
Review Boards who review human
research with pesticides to ensure it
meets applicable standards of ethical
conduct.
This listing is not intended to be
exhaustive, but rather provides a guide
for readers regarding entities likely to be
affected by this action. Other types of
entities not listed in this unit could also
be affected. The North American
Industrial Classification System
(NAICS) codes are provided to assist
you and others in determining whether
this action might apply to certain
entities. If you have any questions
regarding the applicability of this action
to a particular entity, consult the person
listed under FOR FURTHER INFORMATION
CONTACT.
B. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI. Do not submit
confidential business information (CBI)
E:\FR\FM\02FEP1.SGM
02FEP1
5736
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
to EPA through regulations.gov or email. Clearly mark the part or all of the
information that you claim to be CBI.
For CBI information in a disk or CD–
ROM that you mail to EPA, mark the
outside of the disk or CD–ROM as CBI
and then identify electronically within
the disk or CD–ROM the specific
information that is claimed as CBI. In
addition to one complete version of the
comment that includes information
claimed as CBI, a copy of the comment
that does not contain the information
claimed as CBI must be submitted for
inclusion in the public docket.
Information so marked will not be
disclosed except in accordance with
procedures set forth in 40 CFR part 2.
2. Tips for preparing your comments.
When submitting comments, remember
to:
a. Identify the document by docket ID
number and other identifying
information (subject heading, Federal
Register date and page number).
b. Follow directions. The Agency may
ask you to respond to specific questions
or organize comments by referencing a
Code of Federal Regulations (CFR) part
or section number.
c. Explain why you agree or disagree;
suggest alternatives and substitute
language for your requested changes.
d. Describe any assumptions and
provide any technical information and/
or data that you used.
e. If you estimate potential costs or
burdens, explain how you arrived at
your estimate in sufficient detail to
allow for it to be reproduced.
f. Provide specific examples to
illustrate your concerns and suggest
alternatives.
g. Explain your views as clearly as
possible, avoiding the use of profanity
or personal threats.
h. Make sure to submit your
comments by the comment period
deadline identified.
II. Background
mstockstill on DSKH9S0YB1PROD with PROPOSALS
A. What would the proposed
amendments do?
The proposed amendments would
change the 2006 rule, published in the
Federal Register issue of February 6,
2006 (71 FR 6138) (FRL–7759–8),
subsequently amended on June 23, 2006
(71 FR 36171) (FRL–8071–6), and
codified at 40 CFR part 26, in the
following substantive respects:
• By broadening the applicability of
40 CFR part 26, subparts K, L, M, and
Q, so these subparts would apply not
only to research submitted to or
considered by EPA under the pesticide
laws, but also to research involving a
‘‘pesticide’’ (as defined in the Federal
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
Insecticide, Fungicide, and Rodenticide
Act (FIFRA) (7 U.S.C. 136(u)) which is
submitted to or considered by EPA
under any other regulatory statute it
administers.
• By incorporating the definition of
‘‘pesticide’’ from FIFRA, as a substance
or mixture of substances intended for
pesticidal effect.
• By deleting from 40 CFR part 26,
subpart K, all references to consent on
behalf of a subject in research involving
intentional exposure to a pesticide by a
subject’s ‘‘legally authorized
representative.’’
• By incorporating into 40 CFR part
26, subparts P and Q, factors to be
considered by EPA and the Human
Studies Review Board (HSRB) in their
review of proposed and completed
research, derived from the
recommendations of NAS in its 2004
Report to EPA, and from the Nuremberg
Code.
The amendments proposed here
would make no changes to the Federal
Policy for the Protection of Human
Subjects (the ‘‘Common Rule’’), which
governs research with human subjects
conducted or supported by EPA and
many other Federal departments and
agencies. EPA’s codification of the
Common Rule appears as subpart A in
40 CFR part 26.
Subparts B, C, and D of 40 CFR part
26 would also be unchanged by these
proposed amendments. These subparts
categorically prohibit any EPA research
involving intentional exposure to any
substance of human subjects who are
children or pregnant or nursing women
(40 CFR part 26, subpart B), and provide
extra protections for pregnant women
and for children who are the subjects of
observational research conducted or
supported by EPA (40 CFR part 26,
subparts C and D).
The proposed amendments would
retain without substantive change the
core provisions of the 2006 rule
applying to the conduct of human
pesticide research by third parties—i.e.,
research neither conducted nor
supported by EPA or another Common
Rule Federal department or agency.
These substantively unchanged
provisions:
• Categorically prohibit new research
involving intentional exposure of
pregnant or nursing women or of
children to a pesticide (40 CFR part 26,
subpart L).
• Apply the provisions of the
Common Rule to third-party human
research involving intentional exposure
of non-pregnant, non-nursing adults to a
pesticide (40 CFR part 26, subpart K).
• Require submission to EPA of
proposals for new covered research
PO 00000
Frm 00018
Fmt 4702
Sfmt 4702
before it is initiated (40 CFR part 26,
subpart K, § 26.1125).
• Require persons who submit to EPA
reports of completed human research on
pesticides to document the ethical
conduct of that research (40 CFR part
26, subpart M).
• Establish an independent HSRB to
review and advise EPA concerning both
proposals for new human research
involving intentional exposure to a
pesticide and reports of completed
research on which EPA proposes to rely
in its actions (40 CFR part 26, subpart
P).
The proposed amendments would
make only minor editorial revisions to
40 CFR part 26, subpart O, which
defines administrative actions available
to EPA to address non-compliance with
40 CFR part 26, subparts A through L.
The proposed amendments would
retain the essential structure of 40 CFR
part 26, subpart P, which defines the
processes of EPA and HSRB review of
proposed and completed research. The
amendments, however, would also add
substantial new clarifying language to
40 CFR part 26, subpart P, as discussed
in detail in Unit IV.C. of this document.
The proposed amendments would
retain the essential structure of 40 CFR
part 26, subpart Q, which defines the
standards to be applied when EPA
proposes to rely on data from completed
research involving intentional exposure
of human subjects to a pesticide. The
amendments, however, would also add
substantial new clarifying language to
40 CFR part 26, subpart Q, as discussed
in detail in Unit IV.D. of this document.
The proposed amendments would not
change the provision in 40 CFR part 26,
subpart Q, forbidding EPA to rely on
any otherwise unacceptable research
involving intentional exposure of
human subjects to a pesticide, except
under extremely restrictive conditions.
These conditions require a public
review by HSRB, an opportunity for
public comment, and a showing by EPA
that to do so would result in a more
protective regulatory standard than
could be justified without reliance on
the unethical research.
B. What is the agency’s authority for
taking this action?
The legal authority for the 2006 rule
on human research is set forth in the
preamble to that final rule (71 FR 6138,
February 6, 2006) (FRL–7759–8). These
proposed amendments to that rule rest
upon the same legal authority. In
particular, the legal authority for
expanding the 2006 rule to cover
research involving the intentional
exposure of a human subject to a
pesticide submitted under any EPA
E:\FR\FM\02FEP1.SGM
02FEP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
regulatory statute is provided by section
201 of the Department of the Interior,
Environment, and Related Agencies
Appropriations Act, 2006, Public Law
109–54 (2006 Appropriations Act), and
FIFRA.
The 2006 Appropriations Act directly
mandates that EPA promulgate a rule on
‘‘third-party intentional dosing human
toxicity studies for pesticides * * *’’
without limiting the rule to pesticide
studies submitted under FIFRA or
section 408 of the Federal Food, Drug,
and Cosmetic Act (FFDCA) (21 U.S.C.
346a).
Additionally, under FIFRA, EPA has
the authority to issue regulations as to
both unregistered and registered
pesticides used in research involving
the intentional exposure of a human
subject, whether or not that research is
conducted for submission under FIFRA.
Section 3(a) of FIFRA authorizes EPA to
regulate the distribution, sale, or use of
any unregistered pesticide in any State
‘‘[t]o the extent necessary to prevent
unreasonable adverse effects on the
environment’’ (defined at FIFRA section
2(bb), in pertinent part, as ‘‘any
unreasonable risk to man or the
environment, taking into account the
economic, social, and environmental
costs and benefits of the use of any
pesticide’’). EPA concludes that there
would be an unreasonable risk to
humans if unregistered pesticides were
used in research involving intentional
exposure of human subjects (or sold and
distributed for such use) that is not
already covered by the Common Rule
absent compliance with the applicable
rules in 40 CFR part 26, as proposed.
The importance of these rules to the
protection of human subjects is
demonstrated in the 2004 Report from
the National Research Council of the
NAS, entitled ‘‘Intentional Human
Dosing Studies for EPA Regulatory
Purposes: Scientific and Ethical Issues’’
(2004 NAS Report) (https://
www.national-academies.org).
Section 25(a) of FIFRA authorizes
EPA to ‘‘prescribe regulations to carry
out the provisions of [FIFRA].’’ (7 U.S.C.
136w(a)). Regulations protecting human
subjects in research involving the
intentional exposure of human subjects
to registered pesticides fall within that
purview. FIFRA provides that a
pesticide may not be registered unless
use of the pesticide under its labeling
will not cause unreasonable risks to
humans or the environment, that a
pesticide may not be used inconsistent
with its label, and that a pesticide may
not be used in human testing unless the
subjects are fully informed regarding the
nature, purpose, and physical and
mental health consequences of the
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
testing and freely volunteer. (See 7
U.S.C. 136(bb), 136a(c)(5), 136j(a)(2)(G),
136j(a)(2)(P)). The 2006 rule and the
amendments proposed in this document
ensure that these provisions regarding
use of registered pesticides in a manner
that does not cause unreasonable risk
and full and free consent in human
testing with pesticides are effectuated.
III. EPA’s Human Subjects Protection
Rules
A. Overarching Principles
EPA is committed to relying on
scientifically sound research that is
ethically conducted, and to
transparency in its review processes and
decision-making. EPA issued the 2006
rule to further these commitments and
nothing in the amendments proposed in
this document will change that. These
proposed amendments can be seen as
increasing the transparency of EPA’s
decision-making process by clarifying
the scope and applicability of the
requirements in 40 CFR part 26,
codifying the scope and approach used
in EPA’s science and ethics reviews of
human research involving pesticides.
B. Appropriations Act of 2006
In August 2005, in the 2006
Appropriations Act, which appropriated
funds for EPA and other Federal
departments and agencies for FY 2006,
Congress included at section 201 the
following provision:
None of the funds made available by this
Act may be used by the Administrator of the
Environmental Protection Agency to accept,
consider or rely on third-party intentional
dosing human toxicity studies for pesticides,
or to conduct intentional dosing human
toxicity studies for pesticides until the
Administrator issues a final rulemaking on
this subject. The Administrator shall allow
for a period of not less than 90 days for
public comment on the Agency’s proposed
rule before issuing a final rule. Such rule
shall not permit the use of pregnant women,
infants or children as subjects; shall be
consistent with the principles proposed in
the 2004 report of the National Academy of
Sciences on intentional human dosing and
the principles of the Nuremberg Code with
respect to human experimentation; and shall
establish an independent Human Subjects
Review Board. The final rule shall be issued
no later than 180 days after enactment of this
Act.
In response, EPA published a
proposed rule in the Federal Register
issue of September 12, 2005 (70 FR
53838) (FRL–7728–2), accepted public
comment until December 12, 2005, and
promulgated on February 6, 2006, a
final rule which took effect on April 7,
2006 (71 FR 6138) (FRL–7759–8). The
2006 rule, as subsequently amended on
June 23, 2006, to extend special
PO 00000
Frm 00019
Fmt 4702
Sfmt 4702
5737
protections to nursing women as well
(71 FR 36171) (FRL–8071–6), is
discussed in Unit III.E. and is now being
further amended by this proposed rule.
C. EPA’s 2006 Rule
1. Summary of contents. The 2006
rule established a set of protections for
people participating as subjects in thirdparty human research with pesticides.
(In this context ‘‘third-party’’ research is
research neither conducted (‘‘firstparty’’) nor supported (‘‘second-party’’)
by EPA or another Common Rule
Federal department or agency.) The
2006 rule bans all third-party research
on pesticides involving intentional
exposure of children or of pregnant or
nursing women. It further forbids EPA
itself to conduct or support any research
involving intentional exposure of
pregnant or nursing women or of
children to any substance. EPA was
required to promulgate the 2006 rule by
the 2006 Appropriations Act.
The 2006 rule also extends the ethical
protections in the Common Rule to
third-party studies of non-pregnant,
non-nursing adult subjects intentionally
exposed to pesticides. The key
provisions of the 2006 rule include:
• Requiring pre-implementation
submission to EPA of protocols and
related information about proposed
research to ensure any future studies
meet high ethical standards.
• Establishing an independent HSRB
to obtain expert peer review of both
proposals for new research intended for
submission to EPA and reports of
completed human research involving
intentional exposure on which EPA
proposes to rely in an action taken
under the pesticide laws.
• Prohibiting EPA from relying on the
results of research in its actions under
the pesticide laws unless EPA
determines that the research meets
acceptance standards derived from the
recommendations in the 2004 NAS
Report.
2. Research with pesticides since
promulgation of the 2006 rule. Contrary
to some predictions, the 2006 rule has
not led to an upsurge in human research
with pesticides for submission to EPA
under FIFRA or FFDCA. Since
promulgation of the 2006 rule EPA has
received no proposals at all for research
on the toxicity of a pesticide to human
subjects, and has received significantly
fewer than were projected proposals for
new research of other kinds (e.g., insect
repellent studies). In the analyses
supporting the 2006 rule, EPA estimated
33 new intentional exposure studies
would be submitted each year; in fact,
only 26 proposals for new research on
pesticides for submission to EPA under
E:\FR\FM\02FEP1.SGM
02FEP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
5738
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
FIFRA and FFDCA have been submitted
over a span of approximately 5 years, or
just over 5 per year.
3. Overview of HSRB reviews. EPA’s
experience in implementing the 2006
rule is critical to understanding the
amendments proposed in this
document. The public meetings of
HSRB have served as key milestones in
the implementation of the 2006 rule,
and the implementation of the 2006 rule
can be best characterized by
summarizing what HSRB has been
called upon to review. HSRB met for the
first time in April 2006, immediately
after the 2006 rule became effective, and
has met 14 times since then, most
recently in October 2010. At these
meetings, HSRB has reviewed both
reports of completed research and
proposals for new research. Specifically,
HSRB has reviewed:
• Completed reports of pre-2006 rule
research reporting toxic endpoints.
These have included intentional
exposure toxicity tests initiated both
before and after passage of the Food
Quality Protection Act (FQPA) in 1996,
as well as therapeutic trials of
substances used both as drugs and as
pesticides, reporting side effects
relevant to EPA pesticide risk
assessments.
• Proposals for and reports of new
research involving intentional exposure
to materials used in the research as
pesticides.
a. Pre-rule research reporting toxic
endpoints. At its first two meetings in
April and May 2006, HSRB reviewed 28
reports of pre-rule research conducted
with 11 substances. At all its subsequent
meetings combined the Board has
reviewed 14 more such reports. Half of
these 42 reports were published; the rest
were unpublished reports submitted
directly to EPA by pesticide companies.
Of the 42 reports, 37 reported nontherapeutic research, and 5 were
published reports of therapeutic trials
that described side effects relevant to
pesticide risk assessments. We
summarize the disposition of each of the
42 studies in the following paragraphs,
and additional details may be accessed
in the study specific reports available on
the HSRB Web site at https://
www.epa.gov/hsrb/index.htm.
Twenty-nine of the 37 nontherapeutic studies reviewed by HSRB
were initiated before the passage of
FQPA in 1996; all reported toxic
endpoints. EPA conducted both science
and ethic reviews of these studies prior
to submission of the studies to HSRB.
EPA science reviewers proposed to rely
on 17 of these 29 studies. HSRB found
13 of these 17 studies scientifically
acceptable under the applicable
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
standards of the 2006 rule. EPA ethics
reviewers found 5 of the 17 clearly
acceptable, and deferred to HSRB
concerning whether the shortcomings
noted in the conduct of the remaining
12 studies rose to the level of
‘‘significant’’ deficiencies relative to
prevailing standards of ethical research
conduct. HSRB found 15 of those 17
studies ethically acceptable under the
applicable standards of the 2006 rule—
§ 26.1703 and § 26.1704. HSRB found 1
study ethically unacceptable because of
deficiencies in risk minimization
procedures that could have led to
serious harm to subjects, and another
unacceptable because incomplete
information provided to subjects
concerning previous studies seriously
impaired their informed consent. These
2 studies found by HSRB to be ethically
unacceptable were among those also
found by HSRB to be scientifically
unacceptable. EPA has not subsequently
relied on any studies deemed either
scientifically or ethically unacceptable
by HSRB.
The 12 remaining pre-FQPA studies
that EPA science reviewers had
proposed to reject concerned dichlorvos
(DDVP). These reports on the effects of
dichlorvos had been submitted by the
registrant to support a proposal to
reduce the inter-species uncertainty
factor in EPA’s DDVP risk assessment.
EPA reviewers found all 12 to be
scientifically unacceptable to reduce the
inter-species factor since a dose
response could not be calculated due to
numerous technical weaknesses. HSRB
concurred. Because the reported
research was deemed scientifically
unacceptable for the proposed use,
neither EPA nor HSRB explicitly
reviewed its ethical conduct. EPA has
not relied on any of these 12 studies.
Turning to the 8 post-FQPA toxicity
studies that EPA presented to HSRB, we
note that they were among a group of
about 20 studies at the center of
controversy before promulgation of the
2006 rule. Other post-FQPA human
toxicity studies were deemed by EPA
science reviewers to be irrelevant to
EPA’s risk assessments, and have not
been considered further.
Of the eight relevant post-FQPA
toxicity studies, EPA science reviewers
found six scientifically acceptable and
proposed to rely on them, found one
more to be clearly scientifically
unacceptable to set a point of departure
because no effect was measured from
the single dose level tested 1, and
deferred to HSRB with respect to the
1 For more details on this finding, see the study
report available on the HSRD Web site at https://
www.epa.gov/hsrb/index.htm.
PO 00000
Frm 00020
Fmt 4702
Sfmt 4702
scientific acceptability of the last one.
HSRB concurred that the first six
studies were scientifically acceptable,
and found both the others unacceptable.
EPA ethics reviewers found four of the
eight studies clearly acceptable, one
clearly unacceptable, and deferred to
HSRB’s judgment whether the
shortcomings noted in the conduct of
the remaining three rose to the level of
‘‘significant’’ deficiencies relative to
prevailing standards of ethical conduct.
HSRB found all but one of these eight
studies ethically acceptable under the
applicable standards in the 2006 rule.
Studies found either scientifically or
ethically unacceptable by HSRB have
not subsequently been relied on by EPA
in any actions.
EPA also proposed to rely on five
published reports of therapeutic trials of
materials that may be used as either
drugs or as pesticide active ingredients.
In these studies the reported toxic
endpoints relevant to EPA pesticide risk
assessments were not the main objective
of the research, they were reported side
effects of treatment when a test material
(which is sometimes used as a pesticide)
was administered as a medication.
HSRB concurred with the EPA science
reviews that these four studies were
scientifically unacceptable, but found
one study scientifically unacceptable for
the purpose EPA proposed. EPA ethics
reviewers and HSRB both found all five
of these studies to be ethically
acceptable under the standards of the
2006 rule.
In summary, EPA and HSRB worked
through the backlog of pre-rule studies
of pesticide toxicity awaiting review
when the 2006 rule was promulgated.
EPA and HSRB agreed about the
acceptability of these studies in most
cases; when there was disagreement,
EPA has accepted HSRB
recommendation. Some pre-rule studies
that met the scientific and ethical
standards defined in the 2006 rule have
been relied upon by EPA in actions
under the pesticide laws, although EPA
has not relied on any studies found
unacceptable by HSRB. Meanwhile, as
EPA completed the reassessment of
tolerances mandated by FQPA, it found
human toxicity testing to be relevant to
only a handful of those assessments.
b. New research involving intentional
exposure of human subjects. In addition
to reviewing pre-2006 rule research,
HSRB has reviewed proposals for new
research involving intentional exposure
of human subjects. EPA developed a
detailed ‘‘framework’’ for its reviews of
these proposals (see the HSRB Web site
at https://www.epa.gov/hsrb/index.htm).
This framework has been used to guide
all subsequent EPA reviews, and has
E:\FR\FM\02FEP1.SGM
02FEP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
been refined in detail to incorporate
suggestions from HSRB. A completed
framework addressing concerns
identified in the 2004 NAS Report and
subsequently by HSRB has been
attached to each EPA review of a
proposal for new research under the
2006 rule.
Since promulgation of the 2006 rule
EPA has received no proposals at all for
new research concerning pesticide
toxicity or metabolism in human
subjects. All submitted proposals for
new research have been for research
involving intentional exposure of
human subjects to registered pesticides
used for pesticidal purposes in the
research itself. This has included
proposals for research to measure the
duration of effectiveness of skin-applied
repellents intended to keep mosquitoes,
ticks, and other pests away from the
treated skin of human subjects, and for
research monitoring occupational
exposure of pesticide handlers as they
mix, load, or apply pesticides in a
variety of agricultural and nonagricultural use scenarios.
Close scrutiny by both EPA and HSRB
of proposals for new repellent
performance testing and worker
exposure monitoring studies has led to
steady and substantial improvement
both in the scientific design of these
studies and in their provision for ethical
treatment of subjects. These reviews
have led to some delays in field research
costly to the study sponsors, but the
sponsors and investigators proposing
these studies have learned how to
design and execute them efficiently and
in full compliance with the standards of
the 2006 rule. These studies provide
essential information about repellent
performance and worker exposure that
is not available except from well
designed, ethically conducted research
involving intentional exposure of
human subjects to pesticides.
i. Repellent performance studies.
Repellent performance studies using
human subjects have been required by
EPA for many years to support
registration of pesticide products
bearing claims to keep mosquitoes,
ticks, or other pests away from treated
human skin. Since 2006, HSRB has
reviewed proposals for 13 new repellent
performance studies testing a total of 29
repellent formulations. EPA and HSRB
identified enough scientific and ethical
deficiencies in their initial review of the
first 2 such proposals that a second
review was required. After they were
revised and resubmitted, both proposals
were reviewed favorably by EPA and
HSRB. All subsequent proposals for new
repellent performance studies have been
found acceptable, with identified
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
needed refinements, upon their first
review by EPA and HSRB.
Five of the 13 proposals have been for
laboratory research with caged insects
or ticks reared in the laboratory and
known to be disease-free. The remaining
studies have been for field studies of
repellency against wild populations of
insects. Three of the 13 studies have
measured the duration of tick repellency
in the laboratory—2 of them
concurrently testing repellency to 2
species of ticks. Two more have
measured the duration of repellency to
biting flies—1 in the laboratory with
laboratory-reared stable flies, and
another in the field measuring
repellency against black flies. The
remaining 8 studies have measured the
duration of repellency against
mosquitoes—7 of them in the field, in
areas where previous monitoring has
not found evidence of infection of
potential disease vectors among the
wild insects present, and 1 in the
laboratory with laboratory-reared,
pathogen-free mosquitoes.
In all these cases, HSRB has
concurred with the EPA science and
ethics reviews, in some cases
recommending further refinements. One
proposal was abandoned by its sponsor
after a favorable HSRB review; 11 more
have been amended consistent with
EPA and HSRB recommendations and
executed. Reports of these 11 have been
submitted to EPA and reviewed by EPA
and HSRB. The most recent proposal is
expected to be executed in the field in
2011.
In one case EPA and HSRB found the
execution of a completed field mosquito
repellency test to have been noncompliant with 40 CFR part 26, subparts
A–L. This study protocol was
subsequently revised and re-executed;
the report of the re-executed study was
found acceptable by EPA and HSRB.
Reports of all the other ten completed
repellent performance studies were
found both scientifically and ethically
acceptable by EPA and HSRB as first
submitted.
ii. Studies of occupational exposure
of pesticide handlers. All other
proposals for new research submitted to
EPA since promulgation of the 2006 rule
have been for research monitoring
exposure of professional pesticide
handlers as they mix, load, or apply
pesticides in well-defined agricultural
and non-agricultural use scenarios. In
such research, experienced workers
performing their usual tasks are
typically monitored at different sites,
representing the range of variation in
use practices, equipment, and other
factors likely to affect exposure.
Potential dermal exposure of the
PO 00000
Frm 00021
Fmt 4702
Sfmt 4702
5739
workers is measured by analyzing
residues in special ‘‘long underwear’’
worn under their normal work clothing,
and by rinsing their hands, face and
neck. Potential inhalation exposure is
measured with a portable air sampler
worn in the breathing zone of each
worker. This type of research has also
long been required by EPA to support its
assessments of worker risk.
Five proposals for field monitoring of
worker exposure submitted to EPA by
an industry consortium were presented
to HSRB in June 2006. These proposals
were from the Agricultural Handlers
Exposure Task Force (AHETF). HSRB
review was highly critical, and called
for substantially greater information
from both the consortium and from EPA
concerning the overall design of the
research program, the statistical design
of the proposed studies, the uses to
which the resulting data would be put
by EPA, and many other aspects of the
proposed research. All five of these
proposals were subsequently withdrawn
so that HSRB criticisms could be
addressed prior to resubmission.
Since that initial review, the overall
designs of the umbrella monitoring
programs of AHETF and the designs
from the Antimicrobial Exposure
Assessment Task Force (AEATF II) have
been fully documented and presented to
HSRB. HSRB continues to review the
design of individual monitoring studies,
but the soundness of the overall
approaches of both the AEATF II and
AHETF programs have been established.
Monitoring studies for four
antimicrobial exposure scenarios
submitted by the AEATF II have been
presented to HSRB and approved with
suggestions for refinements by both EPA
and HSRB. These four scenarios involve
common methods of application of
antimicrobial pesticide products,
including mopping, wiping down
surfaces with a pre-soaked ready-to-use
wipe, spraying surfaces with a pump
spray and wiping them down with a
cloth, and spraying surfaces with an
aerosol product that does not need to be
wiped off. For each scenario, monitoring
of workers at three distinctive locations
was proposed. After amendment of the
protocols consistent with EPA and
HSRB recommendations, the first three
of these four studies have been
executed; the first complete scenario
report was submitted to EPA and
reviewed by HSRB in October 2010. The
remaining reports of completed AEATF
II exposure research were submitted to
EPA in the fall of 2010, and are
scheduled for presentation to HSRB in
early 2011.
Monitoring studies for four
agricultural exposure scenarios
E:\FR\FM\02FEP1.SGM
02FEP1
5740
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
mstockstill on DSKH9S0YB1PROD with PROPOSALS
submitted by the AHETF have been
presented to HSRB and approved, again
with suggestions for refinements by both
EPA and HSRB. These scenarios involve
application of liquid pesticides to trellis
and orchard crops using ‘‘air-blast’’
spray equipment with closed cabs,
application of liquid pesticides using
air-blast spray equipment with open
cabs, mixing and loading pesticides sold
in water-soluble packaging into a wide
variety of application equipment, and
application of herbicides to rights-ofway. Each of these scenarios calls for
monitoring workers in five different
regions of the United States, working
with different kinds of equipment and
crops. The first two of these four studies
have been executed; the first complete
scenario report was submitted to EPA
and reviewed by HSRB in October 2010.
Reports of the remaining research
scenarios will be submitted to EPA and
presented to HSRB in 2011.
D. Legal Challenge to the 2006 Rule
In early 2006, the Natural Resources
Defense Council, Inc., Pesticide Action
Network North American, Pineros y
Campesinos Unido Del Noroeste,
Physicians for Social Responsibility—
San Francisco, Farm Labor Organizing
Committee, ALF–CIO, and Migrant
Clinicians Network petitioned for
review of the 2006 rule in the United
States Court of Appeals for the Second
Circuit (Second Circuit Court of
Appeals). (NRDC v. EPA, No. 06–0820ag (2d Cir.)). The Petitioners argued that
the 2006 rule violated the 2006
Appropriations Act because it did not
bar all pesticide research with pregnant
women and children, was inconsistent
with the 2004 NAS Report, and was
inconsistent with the Nuremburg Code.
The following paragraphs describe the
Petitioner’s arguments in greater detail.
1. Inadequate bar against research
with pregnant women and children.
Petitioners argued that the scope of the
2006 rule’s ban on research with
pregnant women and children was
unlawfully narrow because it was
limited to studies intended for
submission to EPA under FIFRA or
FFDCA—the pesticide regulatory laws
EPA administers. Petitioners argued that
Congress’s direction to EPA in the
Appropriations Act to ‘‘not permit the
use of pregnant women, infants, or
children as subjects’’ in ‘‘intentional
dosing human toxicity studies for
pesticides’’ did not allow EPA to
distinguish between studies originally
intended for publication and those
intended for submission to EPA, or
between studies with pesticides
conducted for consideration under
FIFRA or FFDCA and those conducted
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
for consideration under the Safe
Drinking Water Act or any other
regulatory statute. Petitioners argued
that EPA’s 2006 rule violated the plain
language of the 2006 Appropriations Act
on this point.
2. Inconsistency with the 2004 NAS
Report. The 2006 Appropriations Act
required EPA’s rule to be consistent
with the principles proposed in the
2004 NAS Report. Petitioners argued
that in citing the ‘‘principles’’ of the
2004 NAS Report, Congress was
referring to the 17 recommendations in
that report. Petitioners further argued
that the 2006 rule was inconsistent with
several specific recommendations in the
2004 NAS Report.
First, Petitioners argued that the 2006
rule did not incorporate
Recommendations 3–1 and 5–1 from the
2004 NAS Report, which recommend
factors to be considered in the scientific
evaluation of human research, including
that such studies should have ‘‘adequate
statistical power’’ and involve
‘‘representative populations for the
endpoint in question.’’
Second, Petitioners argued that the
2006 rule did not incorporate
Recommendations 4–1 and 4–2 from the
2004 NAS Report, which suggest ethical
considerations relevant to evaluation of
human studies.
Third, Petitioners argued that by
adding qualifying language to the
acceptance standard for pre-rule
research suggested in Recommendation
5–7 from the 2004 NAS Report, EPA
made it inconsistent with the 2004 NAS
Report. Petitioners argued that EPA’s
addition of the word ‘‘significantly’’ to
the recommended acceptance standard,
which permits EPA to rely on research
not ‘‘significantly’’ deficient relative to
prevailing standards, made the criterion
in the 2006 rule unlawfully inconsistent
with the recommendations in the 2004
NAS Report.
Finally, Petitioners argued that the
2006 rule unlawfully failed to require
provision of medical care for study
participants, as suggested by
Recommendation 5–5 from the 2004
NAS Report.
3. Inconsistency with the Nuremberg
Code. The 2006 Appropriations Act also
required EPA’s rule to be consistent
with the principles in the Nuremberg
Code pertaining to human
experimentation. Petitioners argued that
the 2006 rule was inconsistent with
several principles in the Nuremburg
Code.
First, Petitioners argued that although
the Nuremberg Code specifies that
consent must be given by the human
subject, the 2006 rule permits consent to
be given in certain situations by a
PO 00000
Frm 00022
Fmt 4702
Sfmt 4702
legally authorized representative of the
subject.
Second, Petitioners argued that the
2006 rule was inconsistent with the
Nuremberg Code principle that a test
subject ‘‘should have sufficient
knowledge and comprehension of the
elements of the subject matter involved
as to enable him to make an
understanding and enlightened
decision.’’ Petitioners argued that the
2006 rule consent requirements were
inadequate to ensure fully informed
consent in the context of research
involving pesticides.
Third, Petitioners argued that the
2006 rule failed to address adequately
the Nuremberg Code principle that a
subject must be ‘‘so situated as to be able
to exercise free power of choice, without
the intervention of any element of force,
fraud, deceit, duress, over-reaching, or
other ulterior form of constraint or
coercion.’’ Petitioners argued that the
requirement of the 2006 rule that
consent should only be sought in
circumstances that ‘‘minimize the
possibility of coercion or undue
influence’’ did not address the potential
for fraud, deceit, over-reaching, or
constraint. Petitioners asserted that
constraint was a particular problem
when prisoners are used as subjects in
human studies, and the 2006 rule did
not specifically address research with
prisoners.
Fourth, Petitioners argued that the
2006 rule was inconsistent with the
Nuremberg Code because it did not
explicitly impose the Nuremburg Code’s
requirement that human studies be
‘‘designed and based on the results of
animal experimentation.’’
Finally, Petitioners argued that the
2006 rule was inconsistent with the
Nuremberg Code principle that human
testing ‘‘should be such as to yield
fruitful results * * * unprocurable by
other methods or means of study, and
not random and unnecessary in nature.’’
Petitioners argued that the 2006 rule
requires no inquiry into whether human
testing is necessary given other methods
of research.
E. Settlement of the Litigation
After briefing and argument, but
before a decision was rendered by the
Second Circuit Court of Appeals, EPA
and Petitioners began negotiations to
settle the litigation. In the settlement
agreement finalized on November 3,
2010, EPA agreed to conduct noticeand-comment rulemaking on the issue
of whether the 2006 rule should be
amended. EPA also agreed to propose, at
a minimum, amendments to the 2006
rule that are substantially consistent
with language negotiated between the
E:\FR\FM\02FEP1.SGM
02FEP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
parties and attached to the settlement
agreement as Exhibit A. This agreement,
including Exhibit A, is available in the
docket for this action as described under
ADDRESSES.
The settlement agreement further
provides that EPA will propose the
negotiated amendments no later than
January 18, 2011, and that EPA will take
final action on the amendments no later
than December 18, 2011. The settlement
agreement, however, makes clear that
EPA retains full discretion concerning
what amendments are proposed, and
what, if any, amendments are finalized.
Although the wording of the
amendments proposed in this document
differs in a few details of construction
and wording, they are substantially
consistent with the regulatory language
negotiated with Petitioners, and EPA
considers these amendments to address
the Petitioners’ major arguments
outlined in Unit III.D. Specifically:
• The proposed amendments would
retain the scope of the 2006 rule to
cover research submitted to EPA under
FIFRA or FFDCA, and extend that scope
to cover as well research involving
intentional exposure to a pesticide,
intended for submission to EPA under
any other regulatory statute
administered by EPA.
• The proposed amendments
incorporate language from each of the
recommendations from the 2004 NAS
Report cited by Petitioners in their
challenge to the 2006 rule, as well as
other pertinent recommendations from
the 2004 NAS Report.
• The proposed amendments address
Petitioners’ arguments concerning the
Nuremberg Code by dropping from 40
CFR part 26, subpart K, all provisions
for consent by a representative, and by
requiring EPA to consider whether
subjects gave their ‘‘free and fully
informed consent’’ to participate in a
study, whether the design of proposed
new human research takes into account
the knowledge gained in earlier animal
testing, and whether proposed new
human research is necessary.
Although these proposed
amendments emerged from a settlement
agreement, EPA believes that proposing
these amendments is consistent with the
language and purposes of the applicable
statutes and because they further the
2006 rule’s goal of ensuring that EPA
does not rely on research involving
intentional exposure of human subjects
to pesticides that is not ethically
conducted or that is not scientifically
sound. EPA believes that many of the
changes proposed in this document are
codifications of the manner in which
EPA and HSRB have interpreted and
implemented the 2006 rule, but
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
welcomes comment on these
interpretations. EPA will fully reevaluate the appropriateness of the
proposed amendments in light of all
comments received in response to this
proposed rule before making a final
determination. In particular, EPA seeks
comment on the relative merits of the
proposed changes compared to retaining
the current scope and content (i.e.,
current wording) of the 2006 rule.
IV. Proposed Amendments, Rationale,
and Request for Comment
This unit provides a description of
each proposed change, the rationale for
the proposed change, and the
anticipated effects of each change
relative to the current regulatory text
(i.e., the 2006 rule). EPA specifically
requests comment on each of these
proposed changes, as well as on the
changes in the aggregate. In particular,
EPA asks for comment on its
conclusions regarding the effect of these
proposed changes, including the effect
of these proposed changes on the
volume of studies covered by the rule,
the likely statutes under which studies
may be submitted, and the impact on
activities covered by those other
statutes, relative to the scope of the 2006
rule.
A. Redefining the Scope and
Applicability of 40 CFR Part 26,
Subparts K, L, M, P, and O
1. Summary of proposed changes.
EPA is proposing amendments that
would modify the scope and
applicability of several subparts of the
2006 rule. The proposed changes would
modify the criteria defining the types of
research covered by 40 CFR part 26,
subparts K, L, and M—most notably the
criteria relating to the intentions of the
sponsor or investigator in conducting
the research or the intentions of the
person submitting the research to EPA.
The specific changes proposed to the
scope and applicability sections of 40
CFR part 26, subparts K, L, M, P, and
Q, are explained here. Although EPA
does not propose to change the text of
the 2006 rule defining the scope of 40
CFR part 26, subpart O, concerning
‘‘Administrative Actions for
Noncompliance,’’ the scope of that
subpart would change nonetheless,
because its applicability depends on the
scope provisions in other subparts that
EPA is proposing to change. More
specifically, these changes alter the
scope as follows: instead of covering
substances under FIFRA, the proposed
amendments would cover pesticides
under all statutes.
In general, the proposed amendments
would shift the focus from whether the
PO 00000
Frm 00023
Fmt 4702
Sfmt 4702
5741
research on the substance was intended
for EPA’s consideration and use under
the pesticide laws, FIFRA and FFDCA,
to whether the research was conducted
with a pesticide and was intended for
EPA’s consideration and use in
connection with an action under any
regulatory statute administered by EPA.
The proposed amendments also would
add a new section to 40 CFR part 26,
subpart P, defining its scope and would
change the scope and applicability of 40
CFR part 26, subpart Q, to parallel the
changes in 40 CFR part 26, subpart K.
2. Summary of anticipated effects.
Although almost all studies with
pesticides are conducted and submitted
to EPA for consideration under FIFRA
or FFDCA, it is possible that some
pesticide studies may be considered by
EPA only under other regulatory
authorities and not be considered under
FIFRA and FFDCA. If studies involving
intentional exposure of humans to a
pesticide are submitted or considered
under other EPA regulatory statutes,
with the proposed amendment, such
studies would be subject to the same
requirements that would have applied
had they been submitted or considered
under FIFRA or FFDCA. In proposing
these amendments, EPA finds that these
changes in scope are consistent with the
focus in the 2006 Appropriations Act on
intentional dosing human toxicity
studies with pesticides.
In sum, EPA does not believe that the
several changes to the ‘‘scope’’ sections
of 40 CFR part 26, subparts K and L—
§ 26.1101 and § 26.1201—and a new
definition of ‘‘pesticide’’ at § 26.1102(c),
that expand the range of human
research to which these two subparts
apply, will result in a significant
increase in the number of studies
reviewed under the rule. However, EPA
recognizes that this is a possibility and
requests comment on whether these
proposed changes are clear about which
studies would fall under the scope of
the rule. EPA knows of no third-party
research involving intentional exposure
of a human subject to a pesticide that
has ever been proposed, conducted, or
submitted to EPA under regulatory
authorities other than the pesticide
laws. The proposed expansion of the
scope of these subparts, however, would
mean that any such studies that are
proposed, conducted, or submitted to
EPA will be governed by the same
standards as pesticide studies submitted
under FIFRA or FFDCA section 408.
3. 40 CFR part 26, subparts K and L—
basic ethical requirements and
prohibitions applying to third-party
research involving intentional exposure
of human subjects to a pesticide.
E:\FR\FM\02FEP1.SGM
02FEP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
5742
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
a. Current rule. Subpart K of 40 CFR
part 26 extends the basic protections of
the Common Rule to subjects in certain
third-party human research; subpart L of
40 CFR part 26 forbids new third-party
research involving intentional exposure
of children or of pregnant or nursing
women. In the 2006 rule these two
subparts apply to ‘‘research with a
human subject’’ which meets four
criteria. First, it was initiated after April
7, 2006 (the effective date of the 2006
rule). Second, it is ‘‘research involving
intentional exposure of a human
subject’’ as defined at § 26.1102(i).
Third, it was conducted or supported by
a ‘‘person’’ as defined at § 26.1102(j).
Fourth, it was intended by any person
conducting or supporting the research to
be submitted to EPA, or to be held for
later inspection by EPA, under the
pesticide laws (FIFRA or FFDCA).
The two cited definitions are critical
to understanding the scope and
applicability of subparts K and L of 40
CFR part 26. ‘‘Research involving
intentional exposure of a human
subject,’’ is defined at § 26.1102(i) as ‘‘a
study of a substance in which the
exposure to the substance experienced
by a human subject participating in the
study would not have occurred but for
the human subject’s participation in the
study.’’ In applying this definition, EPA
considers whether a test subject would
have experienced equivalent exposure
to a test material had the subject not
participated in the research. If not, the
research is deemed to involve
intentional exposure of the subject.
Notably this definition encompasses all
classes of test substances—not only
pesticides.
A ‘‘person’’ is defined at § 26.1102(j) to
have the same meaning as in FIFRA
section 2(s) (7 U.S.C. 136(s)), except that
it excludes Federal agencies subject to
the Common Rule and any person when
performing research supported by a
Common Rule Federal department or
agency. This exclusion is appropriate
because that research is covered by the
Common Rule, which provides
necessary and appropriate protections
for the research subjects. Thus, research
already covered by the standards of the
Common Rule is not also subject to
subparts K and L. These subparts, in
short, apply only to ‘‘third-party
research’’—research that is neither
conducted (‘‘first-party’’) nor supported
(‘‘second-party’’) by EPA or another
Common Rule Federal department or
agency.
Finally, § 26.1101(g) explains how
EPA will approach determination of the
intent of sponsors or investigators to
submit research to EPA under the
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
pesticide laws, or hold it for inspection
by EPA under the pesticide laws.
b. Proposed amendments, rationale,
and anticipated effect. The amendments
proposed in this document would not
change the definitions of ‘‘research
involving intentional exposure of a
human subject’’ or of ‘‘person.’’ They
would add a new definition of
‘‘pesticide’’ at § 26.1102(c), and would
modify the applicability provisions in
§ 26.1101, as explained later in this Unit
of the document.
The first of the four criteria for
application of 40 CFR part 26, subpart
K, will change to incorporate the
effective date of a final rule amending
the 2006 rule. EPA believes it would be
inappropriate to apply these proposed
amendments retroactively. For example,
if post-2006 research newly covered by
an amended rule as proposed in this
document were submitted to EPA, its
acceptability should not be judged by its
compliance with a rule promulgated
after it was conducted. Until the 2006
rule is amended by a final rule, its
provisions continue to apply fully to
new research. Hence no sponsor or
investigator subject to the 2006 rule
would be relieved by the change in the
effective date of any obligation to
comply with 40 CFR part 26, subparts
K and L, for research initiated between
April 7, 2006, and the effective date of
any subsequent amendments.
The proposal would modify the
second of the four criteria so that 40
CFR part 26, subparts K and L, would
apply to research involving intentional
exposure of a human subject ‘‘to a
pesticide’’ when the research is intended
for submission to EPA under any
regulatory statute other than FIFRA or
FFDCA. The definition of ‘‘research
involving intentional exposure of a
human subject’’ would not change, nor
would the applicability of these
subparts to all new third-party research
involving intentional exposure of
human subjects which is intended for
submission to EPA under FIFRA or
FFDCA.
In determining whether research
involves intentional exposure to a
pesticide, EPA will focus, as does the
FIFRA definition of a ‘‘pesticide,’’ on the
intended use of the substance. EPA
expects that application of this standard
will nearly always be straightforward.
However, EPA recognizes that there may
be cases where making such a
determination may not be as
straightforward. EPA will apply this
criterion as follows.
Initially, EPA will examine the study
on its face. If the study states that it
involves the testing of a pesticide, or if
the tested substance is used for
PO 00000
Frm 00024
Fmt 4702
Sfmt 4702
pesticidal effect in the study, as it is in
insect repellent efficacy testing or in
monitoring exposure of pesticide
applicators, there can be little question
that the study involves exposure to a
pesticide. If on the other hand the study
reports testing of another type of
substance, such as an industrial
chemical, waste product, or air
pollutant, then absent compelling
evidence to the contrary, EPA will not
treat the study as involving exposure to
a pesticide.
If it is not clear from the face of the
study whether it involves exposure to a
pesticide, EPA will look to other
objective factors to determine whether a
substance is being tested as a pesticide.
Intent to test a substance as a pesticide
could be indicated by evidence that the
testing was conducted or supported by
an entity regulated under FIFRA or
section 408 of FFDCA; the testing was
conducted for the purpose of attaining
a FIFRA registration or FFDCA
tolerance; there are not significant
commercial uses for the substance other
than as a pesticide; or human exposure
to the substance occurs primarily from
its use as a pesticide. Absent any such
evidence, EPA will generally treat the
study as not involving exposure to a
pesticide.
EPA expects that in most cases, the
question of whether the study involves
exposure to a pesticide will be quickly
resolvable without looking to other
objective factors such as the four
identified in the previous paragraph.
EPA believes that this would be true
even for multiple-use substances that
may be used as a pesticide and may also
result in human exposure from other
commercial uses or as a result of
deposition in the environment as a
waste product.
A good example of how EPA will
determine if studies on multi-use
substances are studies on a pesticide is
presented by sulfur dioxide (SO2)—a
registered pesticide active ingredient
used as a fungicide in grape culture, and
also a common air pollutant. Thousands
of tons of SO2 are released yearly into
the atmosphere by burning of coal and
other fossil fuels. In promulgating
National Ambient Air Quality Standards
(NAAQS) for SO2 under the Clean Air
Act (CAA) in 2010, EPA relied on
numerous human studies involving
intentional exposure of subjects to SO2.
Most of these studies on their face
indicate clearly that they tested SO2 as
an industrial air pollutant and not as a
pesticide. The few that do not expressly
state they tested SO2 as an air pollutant
are, nonetheless, easily classified as not
involving exposure to a pesticide,
because the testing was not conducted
E:\FR\FM\02FEP1.SGM
02FEP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
or sponsored by a pesticide registrant,
the studies do not indicate they were
performed in support of FIFRA
registration, and there are clearly other
major sources of human exposure to SO2
in addition to whatever pesticide
exposure occurs. Thus, these studies
would not come within the scope of the
2006 rule if the scope is modified as
proposed.
EPA specifically requests comment on
the implications of this change for the
volume of studies that may need to be
reviewed under such a proposed
amendment.
The amendments proposed in this
document would not change the
applicability of 40 CFR part 26, subparts
K and L, to ‘‘persons’’ or the definition
of that term at § 26.1102(j). Thus the
third of the four criteria would not be
affected by these proposed amendments.
The fourth criterion would be
broadened by the amendments proposed
in this document beyond the scope of
the 2006 rule. The 2006 rule applies to
research with any substance, conducted
with intent to submit its results to EPA
under FIFRA or FFDCA; as proposed
here, the rule would apply as well to
research with a pesticide, conducted
with intent to submit its results to EPA
‘‘for consideration in connection with
any action that may be performed under
any regulatory statute administered by
EPA’’ other than FIFRA or FFDCA.
The new element in this fourth
criterion, putting aside the proposed
amendment to refer to ‘‘pesticides,’’ is
the reference to actions taken ‘‘under
any regulatory statute administered by
EPA.’’ Research intended for submission
under FIFRA or FFDCA is covered by
the 2006 rule and would continue to be
covered under proposed § 26.1101(a)(1).
Proposed § 26.1101(a)(2) would broaden
the scope of subparts K and L of 40 CFR
part 26 to apply as well to research
involving intentional exposure of a
human subject to a pesticide which is
intended for submission to EPA for
consideration in connection with any
action that may be performed under any
regulatory statute other than FIFRA or
FFDCA. Such submission could be
made under CAA, the Safe Drinking
Water Act (SDWA), the Clean Water Act
(CWA), the Resource Conservation and
Recovery Act (RCRA), the
Comprehensive Environmental
Response, Compensation and Liability
Act (CERCLA, or the Superfund law), or
other similar statutes. EPA specifically
seeks comment on the scope of this
proposed change (i.e., the frequency
with which it might be triggered,
including other statutes to which the
proposed change would apply) and the
implications of the proposed changes on
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
the activities governed by those other
regulations. EPA seeks comment on the
relative merits of this change compared
to retaining the current scope of the
2006 rule. As noted, EPA does not
expect that these wording changes will
result in any substantive changes to the
number or manner in which studies are
currently reviewed.
As an example, EPA’s Office of Water
has, in the past, set Maximum
Contaminant Levels (MCLs) under the
SDWA with pesticides found in
drinking water. Under the proposed
amendment to the scope of 40 CFR part
26, subpart K, any new third-party study
involving intentional exposure of a
human to a pesticide, and intended for
submission to the Office of Water for
consideration in setting a MCL, would
now be subject to 40 CFR part 26,
subpart K, including the requirement of
§ 26.1125 for submission of the proposal
for prior review by EPA and HSRB. EPA
would note that this is a theoretical
example in that it is unaware of any
such study having been submitted with
regard to a MCL.
EPA actions not taken under the
authority of regulatory statutes would
not satisfy this fourth criterion. For
example, an EPA comment on another
Federal department’s or agency’s
Environmental Impact Statement would
not constitute an action taken under a
regulatory statute, and research
intended for submission solely for
consideration in such a context would
not be subject to 40 CFR part 26,
subparts K and L.
EPA interprets the word ‘‘action’’ in
this context broadly, embracing both
regulatory and non-regulatory actions.
Regulatory actions include, for example,
cancellation or registration of a
pesticide, establishment of a tolerance
for a pesticide residue in food, or
establishing a MCL for a pesticide active
ingredient under SDWA. Non-regulatory
actions include, for example, risk
assessments of pesticide active
ingredients, recommended (nonbinding) safe levels of exposure such as
Health Advisory Limits when these
pertain to pesticides, or clean-up
standards for pesticides at a Superfund
site.
The amendments proposed in this
document include two additional
editorial revisions to clarify the scope
sections of 40 CFR part 26, subparts K
and L. One change would clarify the
applicability of 40 CFR part 26, subpart
K, by moving the exposition of how EPA
will determine intent to submit from
§ 26.1101(g), where it appears in the
2006 rule, to § 26.1101(b), immediately
following the presentation of the four
criteria. The other would amend
PO 00000
Frm 00025
Fmt 4702
Sfmt 4702
5743
§ 26.1201, the scope section of 40 CFR
part 26, subpart L, to state simply that
40 CFR part 26, subpart L applies to all
research subject to 40 CFR part 26,
subpart K.
4. 40 CFR part 26, subpart M—
requirement for documentation of the
ethical conduct of completed human
research submitted to EPA.
a. Current rule. Subpart M of 40 CFR
part 26 requires those who submit the
results of human research to EPA for
consideration under the pesticide laws
to submit information documenting the
ethical conduct of the completed
research. Under the 2006 rule, 40 CFR
part 26, subpart M, applies when a
‘‘person’’ as defined at § 26.1102(j)
submits after the effective date of the
2006 rule a report containing the results
of any human research to EPA for
consideration under the pesticide laws.
These criteria differ from those
defining coverage by 40 CFR part 26,
subparts K and L, in important ways.
First, unlike other subparts of the 2006
rule, subpart M applies to submissions
after the effective date of the rule of any
and all human research, without regard
to who conducted it, when, or for what
purpose, or whether or not the reported
research involved intentional exposure
of a human subject. Second, subpart M
applies only when a person (other than
a Federal department or agency subject
to the Common Rule) submits the
results of human research to EPA.
Subpart M does not apply when EPA,
on its own initiative, retrieves published
articles or otherwise obtains information
derived from human research.
b. Proposed amendments and
rationale. EPA proposes to broaden the
applicability of 40 CFR part 26, subpart
M, by amending § 26.1301, while
leaving the substantive requirements of
subpart M unchanged. Specifically, EPA
proposes to include submissions of
reports of human research on pesticides
for consideration by EPA under
regulatory statutes other than FIFRA or
FFDCA. Under the proposed
amendments, subpart M would apply
when a ‘‘person’’ as defined at
§ 26.1102(j) submits after the effective
date of the amended rule a report
containing the results of any human
research to EPA for consideration under
FIFRA or FFDCA, or a report containing
the results of any human research on or
with a pesticide for consideration under
any other regulatory statute
administered by EPA.
The proposed amendments to 40 CFR
part 26, subpart M, attempt to balance
the need for full information on ethical
issues with a concern that the public not
be deterred from submitting scientific
data relevant to EPA information
E:\FR\FM\02FEP1.SGM
02FEP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
5744
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
requests. Section 26.1303 requires a
submitter to provide ‘‘information
concerning the ethical conduct’’ of the
human research, including copies of
relevant IRB records, and copies of
records relevant to the key ethical
considerations outlined in § 26.1117
and § 26.1125(a). This requirement is
qualified by the provision that such
records need only be provided ‘‘[t]o the
extent [the records] are available to the
submitter and not previously provided
to EPA,’’ but any submitter not
providing the information required must
‘‘describe the efforts made to obtain the
information.’’
To minimize the potential burden on
commenters, EPA considered excluding
from the coverage of 40 CFR part 26,
subpart M, submissions of published
scientific journal articles reporting
human research, or of citations to such
articles. In some circumstances,
however, EPA believes it is important
for submitters of even published human
research to bear the burden of gathering
the information required by § 26.1303.
Specifically, EPA believes a submitter of
published human research who is
seeking action under a regulatory statute
from EPA that would directly benefit
the submitter should be obliged to
gather records bearing on the conduct of
the research, even if the research is
described in the public literature. For
example, an applicant for a pesticide
registration or a party petitioning for a
pesticide tolerance should have to
exercise reasonable efforts to obtain
records of the ethical conduct of
research relied on to support the EPA
action sought, whether or not the
research happens to be described in a
scientific journal. Reasonable efforts in
these circumstances may include
seeking relevant records from the
research administrator or the overseeing
IRB. On the other hand, if a member of
the public responds to an EPA request
for information on a pesticide by citing
or submitting a published study, EPA
believes that certification that the
submitter did not sponsor, participate
in, or otherwise have personal
knowledge of or responsibility for the
referenced research would satisfy the
submitter’s obligation under 40 CFR
part 26, subpart M.
c. Anticipated effect. EPA’s concern
for the potential burden of 40 CFR part
26, subpart M, on the public is tempered
by its experience under the 2006 rule.
Since promulgation of the 2006 rule
EPA has received very few submissions
of reports of human research on or with
a pesticide for consideration under
FIFRA or FFDCA, and EPA expects
submissions of such studies to EPA for
consideration only under other
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
regulatory statutes will be even less
common.
EPA specifically requests comments
on this approach to and interpretation of
the requirements in 40 CFR part 26,
subpart M. Such comments should
address whether the proposed rule
language is adequate to implement
EPA’s interpretation.
5. 40 CFR part 26, subpart P—EPA
and HSRB review of proposed and
completed human research.
a. Current rule. Subpart P of 40 CFR
part 26 applies to EPA and HSRB
reviews of proposals for new research
involving intentional exposure of a
human subject, and EPA and HSRB
reviews of reports of completed research
involving intentional exposure of a
human subject and on which EPA
proposes to rely in an action under the
pesticide laws. Unlike other subparts of
the 2006 rule, subpart P does not
include a ‘‘scope’’ section; its
applicability is defined only indirectly
by references to other subparts.
b. Proposed amendments and
rationale. EPA proposes to make
explicit the applicability of 40 CFR part
26, subpart P, in a new § 26.1601. This
proposed new section provides that 40
CFR part 26, subpart P, applies to EPA
and HSRB reviews of (1) ‘‘proposed
research subject to 40 CFR § 26.1125,’’
and (2) ‘‘reviews by EPA after [effective
date of the amended rule] and, to the
extent required by § 26.1604, by the
Human Studies Review Board, of
reports of completed research subject to
40 CFR 26.1701.’’
c. Anticipated effect. Since 40 CFR
26.1125 is in subpart K and 40 CFR
26.1701 is in subpart Q, the broadened
scope of these subparts as proposed in
these amendments would indirectly
broaden the scope of 40 CFR part 26,
subpart P.
6. 40 CFR part 26, subpart Q—ethical
standards for assessing whether to rely
on the results of human research in EPA
actions.
a. Current rule. Subpart Q of 40 CFR
part 26 defines ethical standards that
must be met for EPA to rely on the
results of human research in actions
taken under the pesticide laws.
Specifically, 40 CFR part 26, subpart Q,
applies to EPA decisions to rely on data
from completed studies involving
intentional exposure of a human
subject, when EPA regards the data as
scientifically valid and relevant to an
action taken under the pesticide laws.
b. Proposed amendments and
rationale. For the same reasons it is
proposing to broaden the applicability
of 40 CFR part 26, subpart K (discussed
in Unit IV.A.1.), EPA proposes to amend
§ 26.1701 to broaden the applicability of
PO 00000
Frm 00026
Fmt 4702
Sfmt 4702
40 CFR part 26, subpart Q. Proposed
§ 26.1701(a) would retain without
change the applicability of 40 CFR part
26, subpart Q, to research involving
intentional exposure of human subjects
to any substance, in the context of EPA
actions taken under FIFRA or FFDCA.
Proposed § 26.1701(b) would extend the
applicability of 40 CFR part 26, subpart
Q, to research involving intentional
exposure of human subjects to a
pesticide, in the context of EPA actions
taken under any other regulatory statute
administered by EPA.
EPA intends to interpret ‘‘action’’ and
‘‘regulatory statute administered by
EPA’’ in 40 CFR part 26, subpart Q, just
as these terms would be interpreted for
40 CFR part 26, subpart K. To make this
scope provision consistent with the
other scope provisions in this proposal,
EPA proposes to depart from the
language negotiated in the settlement
agreement and define the scope of 40
CFR part 26, subpart Q, in terms of the
‘‘research’’ covered rather than the
‘‘decisions’’ covered.
c. Anticipated effect. EPA expects this
change in the scope of 40 CFR part 26,
subpart Q, to affect few, if any, EPA
actions. Although such actions may
occur in the future, EPA cannot identify
any actions taken since 2006 under any
regulatory statute other than FIFRA or
FFDCA that relied on research involving
intentional exposure of a human subject
to a pesticide.
As explained previously, EPA is
authorized to propose this change
because it is consistent with the 2006
Appropriations Act. This proposal
would mean that all intentional human
studies involving pesticides submitted
to EPA would be reviewed under the
same ethical and scientific criteria. On
the other hand, EPA has also noted that
it expects this change will affect few
additional studies and may create some
uncertainty as to what studies are
covered by the rule.
EPA specifically invites comment on
the value of making this change and
whether there are additional factors to
be considered in evaluating the
appropriateness of the change, such as
the frequency with which it might be
triggered, including other statutes to
which the proposed change would
apply, and on the clarity of the
proposed changes.
B. Disallowing Consent by a Surrogate
(40 CFR Part 26, Subpart K)
1. Current rule. In the 2004 NAS
Report to EPA, the NAS recommended
use of the Common Rule as the starting
point for protecting human subjects in
research involving intentional exposure.
Consistent with this recommendation,
E:\FR\FM\02FEP1.SGM
02FEP1
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
mstockstill on DSKH9S0YB1PROD with PROPOSALS
EPA incorporated much of the text of
the Common Rule into subpart K of 40
CFR part 26, including language
providing for consent for a subject’s
participation in research by the subject’s
‘‘legally authorized representative’’
when the subject lacks the capacity to
consent for himself or herself. The
Common Rule, drafted to protect
subjects in a wide variety of research
settings, included these provisions to
permit research in various situations,
including, for example, research into
emergency procedures to save lives of
unconscious patients, into improved
care for people suffering psychosis or
schizophrenia, and to collect valuable
data from research with other subjects
who lacked the legal capacity to provide
fully informed, fully voluntary consent.
2. Proposed amendments and
rationale. EPA proposes to amend 40
CFR part 26 by deleting from subpart K
all references permitting consent by a
subject’s legally authorized
representative. The sections affected are
the definition of ‘‘legally authorized
representative’’ at § 26.1102(c); the
‘‘Criteria for IRB approval of research’’ at
§ 26.1111; the ‘‘General requirements for
informed consent’’ at § 26.1116; and the
requirements for ‘‘Documentation of
informed consent’’ at § 26.1117.
EPA proposes to disallow consent by
a representative in third-party studies
because the types of research that are
conducted on pesticides would not use
subjects for whom such a procedure is
needed. (The research covered by 40
CFR part 26, subpart K includes
research involving intentional exposure
of non-pregnant, non-nursing adults to a
pesticide or research involving
intentional exposure of non-pregnant,
non-nursing adults intended for
submission under FIFRA or FFDCA.)
3. Anticipated effect. EPA has never
seen, and cannot envision, any such
research in which it could be justified
to enroll subjects lacking the capacity to
consent for themselves. EPA does not
propose to modify the provisions of 40
CFR part 26, subpart A, EPA’s
codification of the Common Rule. 40
CFR part 26, subpart A, applies to a
much broader range of research with
human subjects conducted or supported
by EPA including research for which
consent by a legally authorized
representative may be appropriate.
C. Revised Standards for EPA and HSRB
Reviews (40 CFR Part 26, Subpart P)
1. Current rule. 40 CFR part 26,
subpart P, defines in largely procedural
terms how EPA evaluates proposals for
new research submitted under § 26.1125
of 40 CFR part 26, subpart K, and how
EPA is to review reports of completed
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
research. Subpart P of 40 CFR part 26
also defines the membership and
responsibilities of HSRB.
2. Proposed amendments and
rationale.
a. Revisions to 40 CFR part 26,
subpart P, generally. The proposed
amendments to 40 CFR part 26, subpart
P, include:
• A proposed new § 26.1601
explicitly defining the applicability of
40 CFR part 26, subpart P, to EPA and
HSRB reviews of proposals for new
research submitted under § 26.1125 of
subpart K and to EPA and HSRB
reviews of reports of completed research
covered by subpart Q. This change is
discussed in Unit IV.A.3.
• A proposed new § 26.1602
references the definitions in 40 CFR part
26, subpart K.
• A proposal to expand the
discussion of EPA reviews of proposed
research in § 26.1603, retaining all
elements of § 26.1601 from the 2006
rule, and including a new § 26.1603(b)
listing considerations to be addressed by
EPA in its science reviews of proposed
research, and a new § 26.1603(c) listing
considerations to be addressed by EPA
in its ethics reviews of proposed
research.
• A proposal to slightly revise
discussion of EPA reviews of completed
research, redesignating § 26.1602 in 40
CFR part 26 as § 26.1604, and revising
paragraph (a) to emphasize the required
thoroughness of EPA’s reviews and to
extend its applicability to reviews of
completed human research on
pesticides considered under regulatory
statutes other than FIFRA or FFDCA.
• The unchanged text of § 26.1603 in
the 2006 rule would be redesignated as
§ 26.1605, defining the membership and
responsibilities of HSRB.
• A proposed new § 26.1606 requiring
HSRB in its reviews of proposed
research to consider the same range of
scientific, ethical, and other topics
addressed by EPA in its reviews under
§ 26.1603.
• A proposed new § 26.1607 requiring
HSRB in its reviews of completed
research to consider both the scientific
and ethical merits of the research, and
to apply the appropriate acceptance
standards in 40 CFR part 26, subpart Q.
As indicated previously and again
throughout this discussion, EPA
requests comment on each of these
proposed changes, as well as on the
changes in the aggregate. EPA also seeks
comments on particular points as
provided in the discussion.
b. Section 26.1603—EPA Review of
proposed human research. Because the
most significant changes proposed are
the new lists in § 26.1603(b) and (c) of
PO 00000
Frm 00027
Fmt 4702
Sfmt 4702
5745
considerations to be addressed in EPA
reviews of proposed new research, those
proposed changes will be discussed in
greater detail here. These proposed lists
were derived primarily from the
following recommendations in the 2004
NAS Report (reproduced verbatim here
and referenced in the subsequent
discussions):
Recommendation 3–1: Scientific Validity of
Intentional Human Dosing Studies
EPA should issue guidelines for
determining whether intentional human
dosing studies have been:
a. Justified, in advance of being conducted,
as needed and as scientifically appropriate,
in that they could contribute to addressing an
important scientific or policy question that
cannot be resolved on the basis of animal
data or human observational data;
b. Designed in accordance with current
scientific standards and practices to (i)
address the research question, (ii) include
representative study populations for the
endpoint in question, and (iii) meet
requirements for adequate statistical power;
c. Conducted in accordance with
recognized good clinical practices, including
appropriate monitoring for safety; and
d. Reported comprehensively to EPA,
including the full study protocol, all data
produced in the study (including adverse
events), and detailed analyses of the data.
Recommendation 4–1: Value of Studies That
Seek to Improve the Accuracy of EPA’s
Decisions But Do Not Provide a Public Health
or Environmental Benefit
EPA should consider a human dosing
study intended to reduce the interspecies
uncertainty factor (for example, a study of a
biomarker such as cholinesterase inhibition)
as conferring a societal benefit only if it was
designed and conducted in a manner that
would improve the scientific accuracy of
EPA’s extrapolation from animal to human
data. Because the anticipated benefit would
not be as great as that conferred by studies
intended to provide a public health or
environmental benefit, the study could be
justified ethically only if the participants’
exposure to the pesticide could reliably be
anticipated to pose no identifiable risk or
present a reasonable certainty of no harm to
study participants.
Recommendation 5–1: Criteria for Scientific
and Ethical Acceptability
Studies that do not meet the highest
scientific and ethical standards should not be
carried out or accepted by EPA as input to
the regulatory decision-making process.
Necessary conditions for scientifically and
ethically acceptable intentional human
dosing studies include:
a. Prior animal studies and, if available,
human observational studies;
b. A demonstrated need for the knowledge
to be obtained from intentional human
dosing studies;
c. Justification and documentation of a
research design and statistical analysis that
are adequate to address an important
scientific or policy question, including
adequate power to detect appropriate effects;
E:\FR\FM\02FEP1.SGM
02FEP1
5746
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
d. An acceptable balance of risks and
benefits and minimization of risks to
participants;
e. Equitable selection of participants;
f. Free and informed consent of
participants; and
g. Review by an appropriately constituted
IRB or its foreign equivalent.
Recommendation 5–2: Participant Selection
Criteria
IRBs reviewing intentional human dosing
studies should ensure that the following
conditions are met in selecting research
participants:
a. Selection should be equitable.
b. Selection of persons from vulnerable
populations must be convincingly justified in
the protocol, which also must justify the
measures to be taken to protect those
participants.
c. Selection of individuals with conditions
that put them at increased risk for adverse
effects in such studies must be convincingly
justified in the protocol, which also must
justify the measures that investigators will
use to decrease the risks to those participants
to an acceptable level.
Recommendation 5–3: Payment for
Participation
IRBs, all relevant review boards,
investigators, and research sponsors should
ensure that payments to participants in
intentional human dosing studies are neither
so high as to constitute undue inducement
nor so low as to be attractive only to
individuals who are socioeconomically
disadvantaged. Proposed levels of and
purposes for remuneration (e.g., time,
inconvenience, and risk) should be
scrutinized in light of the principles of
justice and respect for persons. Moreover,
EPA, in conjunction with other Federal
agencies, should consider developing further
guidance on remuneration for participation
in intentional human dosing studies,
including guidance regarding whether
remuneration should reflect the level of risk
as well as the time and inconvenience
involved.
mstockstill on DSKH9S0YB1PROD with PROPOSALS
Recommendation 5–5: Compensation for
Research-Related Injuries
At a minimum, sponsors of or institutions
conducting intentional human dosing studies
should ensure that participants receive
needed medical care for injuries incurred in
the study, without cost to the participants. In
addition, EPA should study whether broader
compensation for research-related injuries
should be required.
Recommendation 6–1: IRB Review of All
Studies
EPA should require that all human
research conducted for regulatory purposes
be approved in advance by an appropriately
constituted IRB or an acceptable foreign
equivalent. Research conducted by EPA
scientists should be reviewed by an EPAauthorized IRB.
[Taken from pages 7–14 of the 2004 NAS
Report (https://www.national-academies.org).]
c. Science Reviews—§ 26.1603(b). The
provisions in proposed § 26.1603(b)
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
include considerations that EPA must
take into account when conducting its
science reviews of proposed research
that would be covered by the rule. In
developing this list of considerations,
EPA relied on recommendations 3–1
and 5–1 from the 2004 NAS Report to
identify specific items that would be
relevant to evaluating the scientific
merit of proposed human research. How
EPA developed the specific language for
each provision follows.
• Proposed § 26.1603(b)(1): Whether
the research would be likely to produce
data that address an important
scientific or policy question that cannot
be resolved on the basis of animal data
or human observational research.
This language is a combination of
recommendations 3–1(a) and 5–1(b) and
(c) from the 2004 NAS Report (see
verbatim text provided in Unit
IV.C.2.b.). The language ‘‘address an
important scientific or policy question’’
reflects excerpts taken from
recommendation 5–1(c). The language
‘‘that cannot be resolved on the basis of
animal data or human observation
research’’ is taken from recommendation
3–1(a). These recommendations are
intended to avoid unnecessary exposure
for human subjects. If animal data or
human observational research were
available to address an important
scientific or policy question, then there
would be no scientific need for
additional human research. EPA relied
primarily on recommendation 5–1 in
formulating the proposed language
because that recommendation addresses
criteria for EPA acceptance of human
research, whereas recommendation 3–
1describes topics that should be covered
in EPA guidelines.
Based on recommendation 5–1, EPA
has phrased the proposed language as
whether the research ‘‘addresses’’ an
important scientific question rather than
use the phraseology ‘‘contributes to
addressing’’ in recommendation 3–1.
The Agency believes its formulation is
clearer and intends to interpret this as
meaning that the research needs to be
designed to obtain data likely to provide
significant insight into important
research questions.
EPA requests comment on whether its
reliance primarily on the language of
recommendation 5–1(c) is appropriate
here, or whether it should have used the
‘‘contributes to’’ language from
recommendation 3–1(a).
• Proposed § 26.1603(b)(2): Whether
the proposed research is designed in
accordance with current scientific
standards and practices to: Address the
research question, include
representative study populations for the
endpoint in question, and have
PO 00000
Frm 00028
Fmt 4702
Sfmt 4702
adequate statistical power to detect
appropriate effects.
Again, this language is a combination
of recommendations 3–1(b) and 5–1(c)
from the 2004 NAS Report (see verbatim
text provided in Unit IV.C.2.b.). The
recommendations highlight the need for
adequate statistical power and
appropriate representative study
populations to ensure the scientific
validity and reliability (and thus ethical
conduct) of human research. To
accommodate these recommendations,
EPA is proposing to adopt language
from the recommendations 3–1(b) and
5–1(c).
For the reason stated in the previous
discussion on proposed § 26.1603(b)(1),
EPA placed primary reliance on
recommendation 5–1. The Agency notes
that the proposed § 26.1603(b)(2)(iii),
which reflects the language in 5–1(c),
differs from the language in 3–1(b),
which says ‘‘meets requirements for
adequate statistical power.’’ The Agency
prefers to propose the language as
contained in 5–1(c) because it does not
believe that there is one specific set of
‘‘requirements’’ with which to evaluate
statistical power. The Agency intends to
evaluate the statistical power of a study
while focusing on the ultimate goal of
ensuring that appropriate effects are
detected rather than on some arbitrary
and undefined set of ‘‘requirements.’’
EPA requests comment on whether
the proposed language is clear and
specifically on this language as
compared to using the language directly
from the recommendation in the 2004
NAS Report.
• Proposed § 26.1603(b)(3): Whether
the investigator proposes to conduct the
research in accordance with recognized
good research practices, including,
when appropriate, good clinical practice
guidelines and monitoring for the safety
of subjects.
This provision reflects excerpts taken
from recommendation 3–1(c) from the
2004 NAS Report (see verbatim text
provided in Unit IV.C.2.b.). Although
the NAS focused on good clinical
practice guidelines, the Agency is
proposing to apply a broader standard
‘‘recognized good research practices’’,
which may include good clinical
practice guidelines when appropriate.
The rationale for this is that some
human research—in fact, all human
research proposed to EPA to be
conducted since promulgation of the
2006 rule—is not conducted in clinical
settings (e.g., field testing of repellents
or worker exposure) and thus good
clinical practice guidelines would be
inappropriate to apply. However, there
may be other general good research
practices that the research community
E:\FR\FM\02FEP1.SGM
02FEP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
employs to ensure scientific integrity of
their studies and safety of the subjects
that would be relevant for the Agency to
consider. One such practice that has
currently been developed is the
Guidelines for Performance Testing of
Skin-Applied Insect Repellent issued in
October 2008, and incorporated into the
OCSPP harmonized test guidelines
library in July 2010, entitled ‘‘Product
Performance Test Guidelines No.
810.3700: Insect Repellents to be
Applied to Human Skin’’ (https://
www.epa.gov/ocspp/pubs/frs/
publications/Test_Guidelines/
series810.htm).
EPA requests comment on this
expansion and also welcomes
suggestions for other good research
practice documents that could be cited
here as well.
d. Ethics Reviews—§ 26.1603(c). The
provisions in proposed § 26.1603(c)
address many important ethical
concerns, including, among other
things, identification and minimization
of risks to participants, equitable
selection of participants, and provision
of medical care for participants. In
developing this list of considerations,
EPA relied on several recommendations
from the 2004 NAS Report, including 4–
1, 5–1, 5–2, 5–3, and 5–5 (see verbatim
text provided in Unit IV.C.2.b.), to
identify specific considerations that
would be relevant to evaluating the
ethics of proposed human research.
Each proposed consideration is
discussed below.
• Proposed § 26.1603(c)(1): Whether
adequate information is available from
prior animal studies or from other
sources to assess the potential risks to
subjects in the proposed research.
This provision reflects excerpts taken
from recommendation 5–1(a) from the
2004 NAS Report (see verbatim text
provided in Unit IV.C.2.b.), which
recommends that animal studies be
available prior to conducting human
studies. This NAS recommendation also
suggests consideration of human
observational studies if available. When
EPA conducts its ethics reviews, it does
and will continue to consider whether
there is adequate information from prior
animal and human observational studies
to understand the level of risk that may
be presented to subjects of the proposed
research. Although the NAS does not
specify in its recommendation the
specific purpose that the information
from prior animal studies or from other
sources, including human observational
studies if available, serves, EPA believes
its use of these studies to assess
potential risks in evaluating the ethics
of a human research proposal subject to
this rule is reasonable and an integral
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
part of determining whether the benefits
of the research outweigh the risks of the
research. The proposed language refers
to ‘‘information * * * from prior animal
studies or from other sources.’’ EPA
intends the reference to ‘‘other sources’’
to include human observational studies,
consistent with recommendation 5–1.
EPA requests comment on whether
the proposed language is clear and
specifically on this language as
compared to using the language directly
from the recommendation in the 2004
NAS Report.
• Proposed § 26.1603(c)(2): Whether
the research proposal adequately
identifies anticipated risks to human
subjects and their likelihood of
occurrence, minimizes identified risks
to human subjects, and identifies likely
benefits of the research and their
distribution.
This provision is based on
recommendation 5–1(d) from the 2004
NAS Report (see verbatim text provided
in Unit IV.C.2.b.), which states that the
necessary conditions for human
research include ‘‘an acceptable balance
of risks and benefits and minimization
of risks to participants.’’ EPA has
separated these two conditions and
addresses minimization of risk in this
paragraph and the balance of risks and
benefits in proposed § 26.1603(c)(3). In
this paragraph, EPA also proposes to
include a consideration of whether the
research proposal adequately identifies
anticipated risks to human subjects and
their likelihood of occurrence and the
likely benefits of the research and their
distribution. These additional
considerations are important in
understanding the overall risk/benefit
picture of proposed human research
covered by this rule. EPA does not
believe that adding these considerations
will impose any additional burden on
stakeholders since this information is
typically provided with research
proposals that are submitted to IRBs and
to the Agency. EPA currently reviews
human research proposals submitted to
it under the 2006 rule with these
considerations in mind.
EPA requests comment on whether it
is appropriate to address minimization
of risk and the risk-benefit balance in
separate paragraphs. EPA has chosen
this approach because it interprets
recommendation 5–1(d) as setting forth
separate and independent
considerations and, given this
interpretation, believes that repeating
the risk-benefit balance language in this
paragraph would be duplicative and
confusing. EPA also recognizes an
alternative view of recommendation 5–
1(d) is that separating the minimization
of risk consideration from the risk-
PO 00000
Frm 00029
Fmt 4702
Sfmt 4702
5747
benefit balance consideration alters the
collective context intended by
recommendation 5–1(d) of the 2004
NAS Report. As such, EPA requests
comments on both approaches as they
apply to the proposed §§ 26.1603(c)(2)
and 26.1603(c)(3).
• Proposed § 26.1603(c)(3): Whether
the proposed research presents an
acceptable balance of risks and benefits.
In making this determination for
research intended to reduce the
interspecies uncertainty factor in a
pesticide risk assessment, the
Administrator must consider
Recommendation 4–1 in the 2004
Report from the National Research
Council of the National Academy of
Sciences (NAS), entitled ‘‘Intentional
Human Dosing Studies for EPA
Regulatory Purposes: Scientific and
Ethical Issues.’’
This provision reflects excerpts taken
from recommendations 5–1(d) and 4–1
from the 2004 NAS Report (see verbatim
text provided in Unit IV.C.2.b.). For
each human research proposal
submitted to the Agency that is covered
by this rule, in addition to considering
whether a study proposal minimizes
risks to the human subjects, EPA is
proposing to consider whether the
proposed research presents an
acceptable balance of risks and benefits
based on, among other things, the
information it considers under the
proposed paragraphs (c)(1) and (c)(2) in
§ 26.1603.
Recommendation 5–1(d) also refers to
‘‘the minimization of risks to
participants.’’ EPA addressed that
consideration in proposed
§ 26.1603(c)(2). The Agency requests
comment on whether another reference
to minimization of risk is nonetheless
needed in this paragraph for consistency
with the 2004 NAS Report.
For research that is intended
specifically to reduce the interspecies
uncertainty factor in a pesticide risk
assessment, the Agency is proposing to
consider whether that study presents an
acceptable balance of risks and benefits
in accordance with process laid out for
evaluating that type of study in
recommendation 4–1 and the attendant
discussion in the 2004 NAS report that
informs the application of that
recommendation. EPA lacks experience
in reviewing proposals for research
intended to reduce the interspecies
uncertainty factor. Since the
promulgation of the 2006 rule, EPA has
received no proposals for such research
and, as noted in Unit IV.A.2. and A.3.,
EPA knows of no third-party research
involving intentional exposure of a
human subject to a pesticide that has
ever been proposed, conducted, or
E:\FR\FM\02FEP1.SGM
02FEP1
5748
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
mstockstill on DSKH9S0YB1PROD with PROPOSALS
submitted to EPA under regulatory
authorities other than the pesticide
laws. However, EPA recognizes that this
is a possibility in the future.
The Agency asks for comment on how
it should consider NAS
recommendation 4–1, if this proposed
amendment were finalized and EPA
received a study proposal for that
purpose, and, given the context of the
proposed expansion to the scope of the
2006 rule as discussed in Unit IV.A.,
whether the proposed § 26.1603(c)(3) is
clear about how NAS recommendation
4–1 might apply to future studies.
• Proposed § 26.1603(c)(4): Whether
subject selection will be equitable.
This provision is taken directly from
recommendations 5–1(e) and 5–2(a)
from the 2004 NAS Report (see verbatim
text provided in Unit IV.C.2.b.).
• Proposed § 26.1603(c)(5): Whether
subjects’ participation would follow free
and fully informed consent.
This provision reflects excerpts taken
from recommendations 5–1(f) from the
2004 NAS Report (see verbatim text
provided in Unit IV.C.2.b.), which
mentions free and informed consent,
and the Nuremberg Code.2
Key aspects or indicators of free and
fully informed consent or legally
effective consent are set out in detail in
§ 26.1116. They include that
information be provided in a form
understandable to the subject, including
information on the purposes and
duration of the research as well as on
the procedures, risks, and any
compensation involved in the research.
Further, the subject must be made aware
that participation in the research is
voluntary, that there is no penalty for
not participating, and that the subject
may withdraw from the research at any
time. The reference in § 26.1603(c)(5) to
‘‘free and fully informed consent’’
emphasizes the centrality of this
concept to the ethics evaluation process.
• Proposed § 26.1603(c)(6): Whether
an appropriately constituted
Institutional Review Board or its foreign
equivalent has approved the proposed
research.
This provision reflects excerpts taken
from recommendations 5–1(g) and 6–1
2 The Nuremburg Code states the importance of
free and fully informed consent and describes the
elements of such consent: ‘‘The voluntary consent
of the human subject is absolutely essential. This
means that the person involved should have legal
capacity to give consent; should be so situated as
to be able to exercise free power of choice, without
the intervention of any element of force, fraud,
deceit, duress, over-reaching, or other ulterior form
of constraint or coercion; and should have sufficient
knowledge and comprehension of the elements of
the subject matter involved as to enable him to
make an understanding and enlightened decision
* * *’’ https://ohsr.od.nih.gov/guidelines/
nuremberg.html.
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
from the 2004 NAS Report (see verbatim
text provided in Unit IV.C.2.b.). Section
26.1125 already requires third-parties
covered by the 2006 rule to obtain IRB
approval before submitting proposals to
EPA under subpart P, and section
26.1601(c) of the current rule allows the
Agency to consider whether foreign
proposed research has undergone
equivalent protective procedures.
• Proposed § 26.1603(c)(7): If any
person from a vulnerable population
may become a subject in the proposed
research, whether there is a convincing
justification for selection of such a
person, and whether measures taken to
protect such human subjects are
adequate.
This provision reflects excerpts taken
from recommendation 5–2(b) from the
2004 NAS Report (see verbatim text
provided in Unit IV.C.2.b.). EPA
recognizes that some individuals who
may become subjects in human research
may be more vulnerable to coercion or
undue influence, for example, prisoners,
persons with mental disabilities, or
economically or educationally
disadvantaged persons. As such, for
proposals in which such individuals
may become a subject of the research,
EPA is proposing to consider whether
the proposal contains a convincing
justification for the selection of those
persons as well as whether any
measures taken to protect those persons
are adequate. The specific language of
recommendation 5–2(b) states that ‘‘IRBs
* * * should ensure that the following
conditions met in selecting research
participants * * * (b) Selection of
persons from vulnerable populations
must be convincingly justified in the
protocol, which also must justify the
measures to be taken to protect the
participants.’’ In drafting this provision
EPA rephrased recommendation 5–2(b)
to convert it to regulatory language. In
doing so, EPA first made this provision
conditional (the ‘‘if’’ clause) because
EPA does not expect that vulnerable
populations will often be included in
human research and there is no reason
to impose a burden on researchers to
justify a situation when it is
inapplicable. EPA also substituted the
requirement that measures taken to
protect such human subjects be
‘‘adequate’’ instead of requiring a
‘‘convincing justification’’ for them.
EPA requests comment on whether
the proposed language is clear and
specifically on this language as
compared to using the language directly
from recommendation 5–2(b) in the
2004 NAS Report.
• Proposed § 26.1603(c)(8): If any
person with a condition that would put
them at increased risk for adverse
PO 00000
Frm 00030
Fmt 4702
Sfmt 4702
effects may become a subject in the
proposed research, whether there is a
convincing justification for selection of
such a person, and whether measures
taken to protect such human subjects
are adequate.
This provision reflects excerpts taken
from recommendation 5–2(c) from the
2004 NAS Report (see verbatim text
provided in Unit IV.C.2.b.). Although
EPA anticipates that persons with
conditions that put them at increased
risk for adverse effects would likely be
screened from participating in human
research subject to this rule, there may
be circumstances when an exception is
warranted. In those instances where
such persons may become subjects in
research covered by this rule, EPA is
proposing to consider whether the
research contains a convincing
justification for the selection of those
persons as well as whether any
measures taken to protect those persons
are adequate to decrease risks to an
acceptable level. The specific language
of recommendation 5–2(b) states that
‘‘IRBs * * * should ensure that the
following conditions met in selecting
research participants * * * (c) Selection
of individuals with conditions that put
them at increased risk for adverse effects
in such studies must be convincingly
justified in the protocol, which also
must justify the measures that
investigators will use to decrease the
risks to those participants to an
acceptable level.’’ For this provision,
EPA followed a similar path in
converting the NAS recommendation
into regulatory language as it did with
proposed § 26.1603(c)(7), i.e., EPA made
the provision conditional and used an
adequacy test rather than a convincing
justification as to evaluating the
measures to protect the subjects.
EPA requests comment on whether
the proposed language is clear and
specifically on this language as
compared to using the language directly
from recommendation 5–2(c) in the
2004 NAS Report.
• Proposed § 26.1603(c)(9): Whether
any proposed payments to subjects are
consistent with the principles of justice
and respect for persons, and whether
they are so high as to constitute undue
inducement or so low as to be attractive
only to individuals who are
socioeconomically disadvantaged.
This provision reflects excerpts taken
from recommendation 5–3 from the
2004 NAS Report (see verbatim text
provided in Unit IV.C.2.b.). Although
this provision overlaps slightly with
proposed §§ 26.1603(c)(4) and
§ 26.1603(c)(7), EPA is proposing to
enumerate a specific consideration for
whether the level of remuneration for
E:\FR\FM\02FEP1.SGM
02FEP1
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
participation in any proposal for human
research covered by this rule is
appropriate, i.e., consistent with the
principles of justice and respect for
persons, and whether it is likely to
induce participation from individuals
from vulnerable populations and affect
the equitable selection of subjects. In
converting the affirmative statement in
recommendation 5–3 into a ‘‘whether’’
statement for regulatory language, EPA
dropped the recommendation’s
‘‘neither—nor’’ phrasing because it is
potentially confusing. EPA believes that,
as drafted, this provision requires
consideration of whether payments are
either too high or too low but requests
comment on this point.
EPA requests comment on whether
the proposed language is clear and
specifically on this language as
compared to using the language directly
from recommendation 5–3 in the 2004
NAS Report.
• Proposed § 26.1603(c)(10): Whether
the sponsor or investigator would
provide needed medical care for injuries
incurred in the proposed research,
without cost to the human subjects.
This provision reflects excerpts taken
from recommendation 5–5 from the
2004 NAS Report (see verbatim text
provided in Unit IV.C.2.b.). EPA is
proposing to consider in its ethics
review of proposed human research
subject to this rule whether medical care
resulting from participation in the
research will be provided without cost
to the human subjects.
As noted throughout this section, EPA
requests comment on whether the
provisions of proposed § 26.1603 are
consistent with the recommendations
from the 2004 NAS Report and whether
the regulatory language chosen by EPA
adequately captures EPA’s intended
goal and is otherwise clear and easily
understood.
D. Revised Acceptance Standards for
Completed Research (40 CFR part 26,
subpart Q)
mstockstill on DSKH9S0YB1PROD with PROPOSALS
1. Overview
a. Current rule. 40 CFR part 26,
subpart Q, establishes standards
governing reliance by EPA under the
pesticide laws on ‘‘scientifically valid
and relevant data from research
involving intentional exposure of
human subjects.’’ Section 26.1703
forbids EPA to rely on any research
involving intentional exposure of a
subject who was a pregnant woman, a
nursing woman, or a child. Section
26.1704 forbids EPA to rely on research
initiated before the effective date of the
2006 rule in the face of clear and
convincing evidence that ‘‘the conduct
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
of the research was fundamentally
unethical (e.g., the research was
intended to seriously harm participants
or failed to obtain informed consent), or
was significantly deficient relative to
the ethical standards prevailing at the
time the research was conducted.’’
Section 26.1705 forbids EPA to rely on
research initiated after the effective date
of the 2006 rule unless EPA has
‘‘adequate information to determine that
the research was conducted in
substantial compliance with subparts A
through L * * *’’ Section 26.1706
permits EPA to rely on the results of
human research unacceptable under the
standards of §§ 26.1703–26.1705 only if
EPA determines, after public notice and
comment and consultation with HSRB,
that reliance on the research is
necessary to support ‘‘a more stringent
regulatory restriction that would
improve protection of public health
* * * than could be justified without
relying on the data.’’ The Agency is not
proposing to amend the substance of
§ 26.1706.
b. Summary of proposed changes. In
addition to broadening the scope of 40
CFR part 26, subpart Q, to apply to
research relied on by EPA under
regulatory statutes other than FIFRA or
FFDCA, EPA proposes to amend the
substantive standards in §§ 26.1703,
26.1704, and 26.1705 for determining
the acceptability of completed research
involving intentional exposure of a
human subject to a pesticide. As noted
throughout this document, EPA requests
comment on each of these proposed
changes, as well as on the changes in
the aggregate. In particular, EPA seeks
comment on its conclusions regarding
the effect of these proposed changes
relative to the scope of the 2006 rule,
including the effect of these proposed
changes on the volume of studies
covered by the rule, the likely statutes
under which studies may be submitted,
and the impact on activities covered by
those other statutes.
c. Anticipated effects. If a covered
study does not meet the applicable
standards in 40 CFR part 26, subpart Q,
EPA would be prohibited from relying
on the data in any action it takes under
any of its regulatory authorities except
under the extremely restrictive
conditions defined in § 26.1706.
2. § 26.1703: Standards Applicable to all
Covered Research
a. Proposed changes and rationale.
Consistent with the changes proposed in
40 CFR part 26, subpart P, and
discussed in Unit IV.C., EPA proposes
to add in § 26.1703(a) an explicit
prohibition against reliance on data
from completed research ‘‘unless EPA
PO 00000
Frm 00031
Fmt 4702
Sfmt 4702
5749
determines that the data are relevant to
a scientific or policy question important
for EPA decision-making, that the data
were derived in a manner that makes
them scientifically valid and reliable,
and that it is appropriate to use the data
for the purpose proposed by EPA.’’
In making this determination, EPA
would be required to assess these four
aspects of the research:
• Whether the research was designed
and conducted according to
‘‘appropriate scientific standards and
practices prevailing at the time the
research was conducted.’’
• The extent to which the test
subjects represent the population whose
response the data will be used to
predict.
• The statistical power of the data to
support the scientific conclusions
drawn by EPA.
• Whether, in a study that reports a
No Observed Effect Level (NOEL) or a
No Observed Adverse Effect Level
(NOAEL), some dose level elicited a
biological effect.
These four aspects of the research are
derived from Recommendations 3–1 and
5–1 from the 2004 NAS Report. They do
not establish fixed criteria for
acceptance or rejection of a study, but
they identify specific aspects of a study
that EPA must consider in determining
that it is relevant, scientifically valid
and reliable, and appropriate for a
particular use.
b. Anticipated effect. As noted
previously, 40 CFR part 26, subpart Q,
applies to EPA decisions to rely on
‘‘scientifically valid and relevant data’’
from covered research. Since 2006,
EPA’s practice in reviewing reports of
covered human research has been to
examine carefully the scientific merit of
the reported studies and to refuse to use
research deemed invalid or irrelevant.
EPA proposes to delete these factors
from the scope of 40 CFR part 26,
subpart Q, as defined in § 26.1701, and
to codify them as factors in § 26.1703(a)
to ensure that they remain central to
determinations of scientific validity and
relevance. If this proposed amendment
is finalized, EPA would likely make
minor revisions to its internal review
procedures to highlight the
consideration given to these four aspects
of the research.
3. § 26.1704: Acceptance Standards for
Research not Subject to § 26.1705
a. Proposed changes and rationale.
The Agency based the ethical
acceptability standard in § 26.1704 on
Recommendation 5–7 from the 2004
NAS Report, which states in relevant
part:
E:\FR\FM\02FEP1.SGM
02FEP1
5750
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
EPA should accept scientifically valid
studies conducted before its new rules are
implemented unless there is clear and
convincing evidence that the conduct of
those studies was fundamentally unethical
(e.g., the studies were intended to seriously
harm participants or failed to obtain
informed consent) or that the conduct was
deficient relative to then-prevailing
standards.
Section 26.1704 provides in relevant
part (emphasis added):
mstockstill on DSKH9S0YB1PROD with PROPOSALS
* * * EPA shall not rely on data from any
research initiated before [the effective date of
the 2006 rule], if there is clear and
convincing evidence that the conduct of the
research was fundamentally unethical (e.g.,
the research was intended to seriously harm
participants or failed to obtain informed
consent), or was significantly deficient
relative to the ethical standards prevailing at
the time the research was conducted.
EPA adopted the recommendation
from the 2004 NAS Report nearly
verbatim, with the notable insertion of
the word ‘‘significantly’’ before
‘‘deficient.’’ EPA explained in the
preamble to the 2006 rule (at 71 FR
6161) that this was to allow it the
flexibility to consider the impact on
subjects of any ethical shortcomings in
the conduct of the research. EPA stated
in that preamble (at 71 FR 6161) that
‘‘EPA expects [the meaning of
‘‘significantly’’] to acquire greater clarity
over time, through HSRB and public
review of Agency decisions concerning
reliance on completed human research.’’
EPA believes that greater clarity has,
indeed, been achieved through the
application of the 2006 rule by EPA and
HSRB. EPA now proposes to revise
§ 26.1704 by deleting the word
‘‘significantly,’’ proposing instead to
characterize explicitly the kinds of
deficiencies that would make a study
unacceptable.
This language is derived from the
advice of HSRB as they have applied the
standard of § 26.1704 in the 2006 rule.
See, for example, their comments on
studies involving aldicarb, methomyl,
oxamyl, azinphos-methyl, DDVP,
ethephon, sodium cyanide, and amitraz
at: https://www.epa.gov/osa/hsrb/files/
meeting-materials/apr-4-6-2006-publicmeeting/
april2006mtgfinalreport62606.pdf. For
each study they found ethically
acceptable, HSRB found ‘‘no evidence of
significant deficiencies in the ethical
procedures that could have resulted in
serious harm (based on the knowledge
available at the time the study was
conducted) nor that information
provided to participants seriously
impaired their informed consent.’’
Finally, EPA proposes to redefine the
applicability of § 26.1704 in a new
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
paragraph (a) as the complement of the
more detailed scope of § 26.1705,
thereby eliminating any gaps or overlap
in the applicability of the two standards.
b. Anticipated effect. Proposed
§ 26.1704 would forbid EPA to rely on
research not covered by 40 CFR part 26,
subpart K, or the Common Rule in the
face of clear and convincing evidence
that its conduct ‘‘placed participants at
increased risk of harm (based on
knowledge available at the time the
study was conducted) or impaired their
informed consent.’’ EPA specifically
requests comment on the incremental
value of this change as well as the
extent to which this change might
inappropriately reduce EPA’s access to
human research.
4. § 26.1705: Standards for Completed
Research Conducted Under 40 CFR Part
26 or Another Codification of the
Common Rule
a. Proposed changes and rationale.
The standard in 40 CFR part 26
applying to completed research initiated
after the effective date of the rule is
§ 26.1705, based on Recommendation 5–
6 from the 2004 NAS Report, which
states in relevant part (italics in the
original; footnote omitted):
EPA should operate on the strong
presumption that data obtained in studies
conducted after implementation of the new
rules that do not meet the ethical standards
described in this report will not be
considered in its regulatory decisions.
EPA adapted this recommendation in
its drafting of § 26.1705, which provides
in relevant part:
EPA shall not rely on data from any
research initiated after [the effective date of
the 2006 rule] unless EPA has adequate
information to determine that the research
was conducted in substantial compliance
with subparts A through L of this part, or if
conducted in a foreign country, under
procedures at least as protective as those in
subparts A through L of this part.
EPA now proposes to amend both the
applicability of § 26.1705 and the
substance of the standard itself. In the
2006 rule, § 26.1705 applies to any
scientifically valid and relevant research
involving intentional exposure of
human subjects and initiated after the
effective date of the rule. EPA proposes
now to limit application of the § 26.1705
standard to research subject, at the time
it was conducted, either to subparts A
through L of 40 CFR part 26 or to
another Federal department or agency’s
codification of the Common Rule.
EPA recognizes that it could in the
future wish to rely on data from thirdparty research conducted after 2006 but
which fell outside the scope of 40 CFR
part 26, subpart K, and for which EPA
PO 00000
Frm 00032
Fmt 4702
Sfmt 4702
therefore would not have conducted a
protocol review under 40 CFR part 26,
subpart P, before the research was
conducted. For example, as discussed in
Unit IV.A., 40 CFR part 26, subpart K,
as now proposed would not apply to a
new clinical trial evaluating the
therapeutic efficacy of a drug that was
also a pesticide. Because this research
would fall outside the scope of 40 CFR
part 26, subpart K, investigators would
not have submitted the protocol to EPA
under 40 CFR part 26, subpart K, and
EPA and HSRB would not have
reviewed it under 40 CFR part 26,
subpart P. Yet, if data from such
research were to be relied on by EPA,
the standards of subpart Q would apply.
As § 26.1705 is currently worded in 40
CFR part 26, such a study could only be
relied on if ‘‘EPA has adequate
information to determine that the
research was conducted in substantial
compliance with subparts A through L.’’
But because the protocol would not
have been submitted for review by EPA
and HSRB, the research in this example
would not have been conducted in
substantial compliance with 40 CFR
part 26, subpart K.
EPA believes that it would be
inappropriate to reject otherwise
meritorious and ethical research for
failure to comply with provisions in 40
CFR part 26, subparts A–L that did not
apply when the research was
conducted. Thus EPA proposes to make
§ 26.1705 applicable only to studies that
were initiated after the effective date of
the 2006 rule and that were subject to
EPA’s rules for the protection of human
subjects (40 CFR part 26, subparts A
through L) or another codification of the
Common Rule. A companion change in
§ 26.1704(a) would apply the standard
of § 26.1704 to all other completed
research considered by EPA under 40
CFR part 26, subpart Q, without regard
to when the research was initiated.
EPA proposes further changes to
§ 26.1705 to help make this clear.
Proposed § 26.1705(b)(1) defines the
applicable standard as either 40 CFR
part 26, subparts A through L, or
another Federal department or agency’s
codification of the Common Rule,
whichever set of rules covered the
research when it was conducted. In
proposed § 26.1705(b)(2), corresponding
changes are made applicable to research
conducted in foreign countries.
Finally, in a new paragraph (c) in
§ 26.1705, EPA proposes to require
substantial compliance of covered
research with its protocol. A study
reviewed as a proposal under subpart P
of 40 CFR part 26 could be relied on
only if it had been conducted in
substantial compliance with the
E:\FR\FM\02FEP1.SGM
02FEP1
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
mstockstill on DSKH9S0YB1PROD with PROPOSALS
protocol found acceptable by EPA, and
if the investigator did not further amend
or deviate from the protocol in ways
that placed participants at increased risk
of harm (based on knowledge available
at the time the study was conducted) or
impaired their informed consent. If a
completed study was not reviewed as a
proposal under 40 CFR part 26, subpart
P, the study could only be relied on if
it had been conducted in substantial
compliance with a protocol that would
have been found acceptable, and if the
investigator did not amend or deviate
from the protocol in ways that placed
participants at increased risk of harm
(based on knowledge available at the
time the study was conducted) or
impaired their informed consent.
b. Anticipated effect. Taken together,
these proposed changes in § 26.1705
reflect the interpretations and methods
used by EPA and HSRB since 2006 in
reviewing completed, post-rule
research. Codifying these interpretations
will ensure consistency and
transparency in future decision-making
and is consistent with the 2006
Appropriations Act.
E. Request for Public Comment on
Possible Re-Codification of 40 CFR Part
26, Subparts K–Q
1. Current rule. Subparts A–D of 40
CFR part 26 all apply to research with
human subjects which is conducted or
supported by EPA in its role as a
research agency. Subparts K–Q of 40
CFR part 26 apply to pesticide research
with human subjects that is conducted
by regulated third parties, and to EPA’s
regulatory oversight of that research.
Some stakeholders have suggested that
this important distinction would be
clearer if 40 CFR part 26 contained only
those subparts applying to EPA as a
research agency, and if 40 CFR part 26,
subparts K–Q, were moved to a different
section of EPA’s regulations, within the
range where other pesticide-specific
regulations are found.
2. Proposed amendments and
rationale. EPA is not now proposing
such a re-codification, but invites public
comment on the idea. Although it
would necessitate many non-substantive
revisions—mainly of internal crossreferences—re-codification would not
be difficult to accomplish. 40 CFR part
26 would retain current 40 CFR part 26,
subparts A–D, and at least parts of
current 40 CFR part 26, subpart O. A
previously unused part within 40 CFR,
within the numerical range of parts
150–180 where other pesticide-related
regulations appear, would include
current 40 CFR part 26, subparts K, L,
M, O, P, and Q. 40 CFR part 26, subpart
O, potentially applies to both EPA
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
research and to third-party research and
would need to be adapted to fit into
both parts of a separated codification in
40 CFR.
3. Anticipated effect. Although this
proposed re-codification may better
distinguish those requirements applying
to EPA as a research agency, and those
applying to third-party studies, it would
only change the location of the
regulation within 40 CFR, and would
not otherwise have any effect on the
requirements.
V. FIFRA Review Requirements
In accordance with FIFRA section
25(a), EPA has submitted a draft of the
proposed rule to the FIFRA Scientific
Advisory Panel (SAP), the Secretary of
Agriculture (USDA), and appropriate
Congressional Committees. The FIFRA
SAP waived its review of this proposal
on October 12, 2010, because the
significant scientific issues involved
have already been reviewed by the SAP
and additional review is not necessary.
USDA responded without comments,
but participated in the interagency
review process under Executive Order
12866.
VI. Statutory and Executive Order
Reviews
A. Regulatory Planning and Review
Under Executive Order 12866,
entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993),
this has been identified as a ‘‘significant
regulatory action.’’ Accordingly, EPA
submitted the draft proposed rule to the
Office of Management and Budget
(OMB) for review under Executive
Order 12866 and any changes made in
response to OMB recommendations
have been documented in the docket for
this rulemaking as required by the
Executive Order.
The incremental costs of these
proposed amendments both to industry
and to EPA are expected to be
negligible. EPA has not, therefore,
prepared a new economic analysis for
this rulemaking. Because no research
has been identified that is outside the
scope of the 2006 rule but that would be
within the scope of these proposed
amendments, EPA has no basis on
which to revise the cost estimates that
were provided in the economic analysis
for the 2006 rulemaking or those most
recently provided in the 2008 renewal
of the Information Collection Request
(ICR) for the existing regulation at 40
CFR part 26. The recent estimates
included in the ICR are summarized in
Unit VI.B. and a copy of the ICR is
available in the docket.
PO 00000
Frm 00033
Fmt 4702
Sfmt 4702
5751
B. Paperwork Reduction Act
This action does not impose any new
information collection burden that
would require additional review or
approval by OMB under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et
seq. OMB previously approved the
information collection requirements
contained in the existing regulations at
40 CFR part 26 under OMB Control No.
2070–0169 (EPA ICR No. 2195). Burden
is defined at 5 CFR 1320.3(b).
In its 2008 analysis supporting the
most recent renewal of this ICR, EPA
estimated that respondents would
submit to the Agency some 34 proposals
for or reports of research involving
intentional exposure of human subjects
each year. EPA estimated that
preparation of information required by
the 2006 rule would require about 598
hours per study at a cost of $45,927 per
study, for a total estimated annual
burden for affected entities of 20,332
hours at an estimated cost of $1,561,518.
In addition, EPA estimated annual
submission of 20 reports of research
requiring only documentation of ethical
conduct at a cost of 12 hours/$879 per
report, or 240 hours/$17,580 per year.
The total estimate of the annual
respondent burden and cost was the
sum of these two estimates, or 2,572
hours/$1,579,098.
These paperwork burden and cost
estimates include activities related to
initial rule familiarization, as well as
activities that researchers would have to
perform even without the Agency’s
rulemaking in this area, such as
developing a protocol and maintaining
records.
The average annual burden on EPA
for reviewing each of the 34 study
submissions was estimated to be 178
hours/$16,850 per study, or 6,052
hours/$572,900 per year. The average
annual burden on EPA for reviewing
each of the 20 additional submissions
was estimated to be 44 hours/$3,158 per
study, or 880 hours/$63,160 per year.
The total estimate of the annual burden
on EPA was the sum of these two
estimates, or 6,932 hours/$636,000 per
year.
In no year since promulgation of the
2006 rule have more than 7 protocols
been submitted to EPA by industry; the
average annual rate has been just over
5 for the 5-year period of 2006–2010.
Somewhat fewer completed reports
have been submitted during this period,
so the average of new protocols and
finished studies has been about 11 per
year, less than a third of the projected
34 per year covered by the ICR. There
is no evidence to suggest an upward
trend, and nothing in these amendments
E:\FR\FM\02FEP1.SGM
02FEP1
5752
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
is believed likely to lead to a significant
change in the rate of protocol and study
submissions.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number. The OMB control
numbers for EPA’s regulations in 40
CFR are listed in 40 CFR part 9.
mstockstill on DSKH9S0YB1PROD with PROPOSALS
C. Small Entity Impacts
Pursuant to section 605(b) of the
Regulatory Flexibility Act (RFA), 5
U.S.C. 601 et seq., the Agency hereby
certifies that this action will not have a
significant adverse economic impact on
a substantial number of small entities.
Under RFA, small entities include small
businesses, small organizations, and
small governmental jurisdictions. For
purposes of assessing the impacts of this
proposed rule on small entities, small
entity is defined in accordance with
RFA section 601 as:
1. A small business as defined by the
Small Business Administration’s (SBA)
regulations at 13 CFR 121.201.
2. A small governmental jurisdiction
that is a government of a city, county,
town, school district or special district
with a population of less than 50,000.
3. A small organization that is any
not-for-profit enterprise which is
independently owned and operated and
is not dominant in its field.
Because no small entities have been
identified that are directly regulated by
these proposed amendments, EPA has
not attempted to reduce the impact of
this proposed rule on small entities.
Comments are invited on all aspects of
the proposal and its impacts on small
entities.
D. Unfunded Mandates
This action does not impose any
enforceable duty, contain any unfunded
mandate, or otherwise have any effect
on small governments subject to the
requirements of sections 202, 203, 204,
or 205 of the Unfunded Mandates
Reform Act (UMRA), 2 U.S.C. 1531–
1538. These amendments are unlikely to
affect State, local, and tribal
governments at all, and are likely to
affect the private sector only trivially.
The action does not contain a Federal
mandate that may result in expenditures
of $100 million or more for State, local,
and tribal governments, in the aggregate,
or the private sector in any 1 year.
E. Federalism
This action does not have federalism
implications because it is not expected
to have substantial direct effects on the
States, on the relationship between the
national government and the States, or
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
on the distribution of power and
responsibilities among the various
levels of government, as specified in
Executive Order 13132, entitled
Federalism (64 FR 43255, August 10,
1999). It makes marginal changes in the
scope of an existing rule applying to
sponsors and investigators conducting
certain kinds of research involving
human subjects, and refines the
standards for EPA oversight of and
reliance on such research.
In the spirit of Executive Order 13132,
and consistent with EPA policy to
promote communications between EPA
and State and local governments, EPA
specifically requests comments on this
proposed action from State and local
officials.
F. Tribal Implications
This action does not have tribal
implications as specified in Executive
Order 13175, entitled Consultation and
Coordination with Indian Tribal
Governments (65 FR 67249, November
9, 2000). This action is not expected to
have substantial direct effects on Indian
Tribes, will not significantly or uniquely
affect the communities of Indian Tribal
governments, and does not involve or
impose any requirements that affect
Indian Tribes. Thus, Executive Order
13175 does not apply to this action.
G. Children’s Health Protection
EPA interprets Executive Order
13045, entitled Protection of Children
from Environmental Health Risks and
Safety Risks (62 FR 19885, April 23,
1997), as applying only to those
regulatory actions that concern health or
safety risks, such that the analysis
required under section 5–501 of the
Executive Order has the potential to
influence the regulation. This action is
not subject to Executive Order 13045
because it does not establish an
environmental standard intended to
mitigate health or safety risks, nor is it
an ‘‘economically significant regulatory
action’’ as defined in Executive Order
12866. The 2006 rule applies to the
conduct and review of research
involving intentional exposure of
human subjects, and prohibits the
conduct of or EPA reliance on any such
research involving subjects who are
children, or pregnant or nursing women.
These provisions would not be affected
by the proposed amendments.
H. Affect on Energy Supply,
Distribution, or Use
This action is not a ‘‘significant energy
action’’ as defined in Executive Order
13211, entitled Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use (66
PO 00000
Frm 00034
Fmt 4702
Sfmt 4702
FR 28355, May 22, 2001), because this
action is not likely to have any affect on
the supply, distribution, or use of
energy.
I. Technical Standards
Because this action does not involve
any technical standards, section 12(d) of
the National Technology Transfer and
Advancement Act of 1995 (NTTAA) (15
U.S.C. 272 note), does not apply to this
action.
J. Environmental Justice
This action does not entail special
considerations of environmental justice
related issues as delineated by
Executive Order 12898, entitled Federal
Actions to Address Environmental
Justice in Minority Populations and
Low-Income Populations (59 FR 7629,
February 16, 1994). The strengthened
protections for human subjects
participating in covered research
established in the 2006 rule would not
be altered by these proposed
amendments.
List of Subjects in 40 CFR Part 26
Environmental protection,
Administrative practice and procedures,
Human research, Pesticides and pests.
Dated: January 18, 2011.
Lisa P. Jackson,
Administrator.
Therefore, it is proposed that 40 CFR
chapter I be amended as follows:
PART 26—[AMENDED]
1. The authority citation for part 26 is
revised to read as follows:
Authority: 5 U.S.C. 301; 7 U.S.C. 136a(a)
and 136w(a)(1); 21 U.S.C. 346a(e)(1)(C); sec.
201, Pub. L. 109–54, 119 Stat. 531; and 42
U.S.C. 300v–1(b).
2. Amend § 26.1101 as follows:
a. Remove paragraphs (a), (c), and (g);
b. Redesignate paragraph (b) as (c), (f)
as (g), (e) as (f), and (d) as (e); and
c. Add new paragraphs (a), (b), and (d)
to read as follows.
§ 26.1101
apply?
To what does this subpart
(a) Except as provided in paragraph
(c) of this section, this subpart applies
to all research initiated on or after
[effective date of final rule] involving
intentional exposure of a human subject
to:
(1) Any substance if, at any time prior
to initiating such research, any person
who conducted or supported such
research intended either to submit
results of the research to EPA for
consideration in connection with any
action that may be performed by EPA
under the Federal Insecticide,
E:\FR\FM\02FEP1.SGM
02FEP1
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
Fungicide, and Rodenticide Act (FIFRA)
(7 U.S.C. 136–136y) or section 408 of
the Federal Food, Drug, and Cosmetic
Act (FFDCA) (21 U.S.C. 346a), or to hold
the results of the research for later
inspection by EPA under FIFRA (7
U.S.C. 136–136y) or section 408 of
FFDCA (21 U.S.C. 346a); or
(2) A pesticide if, at any time prior to
initiating such research, any person who
conducted or supported such research
intended either to submit results of the
research to EPA for consideration in
connection with any action that may be
performed by EPA under any regulatory
statute administered by EPA other than
those statutes designated in paragraph
(a)(1) of this section, or to hold the
results of the research for later
inspection by EPA under any regulatory
statute administered by EPA other than
those statutes designated in paragraph
(a)(1) of this section.
(b) For purposes of determining a
person’s intent under paragraph (a) of
this section, EPA may consider any
available and relevant information. EPA
must rebuttably presume the existence
of intent if:
(1) The person or the person’s agent
has submitted or made available for
inspection the results of such research
to EPA; or
(2) The person is a member of a class
of people who, or whose products or
activities, are regulated by EPA and, at
the time the research was initiated, the
results of such research would be
relevant to EPA’s exercise of its
regulatory authority with respect to that
class of people, products, or activities.
*
*
*
*
*
(d) The Administrator retains final
judgment as to whether a particular
activity is covered by this subpart.
*
*
*
*
*
3. In § 26.1102, revise paragraphs (a)
and (c) and add paragraph (k) to read as
follows:
mstockstill on DSKH9S0YB1PROD with PROPOSALS
§ 26.1102
Definitions.
(a) Administrator means the
Administrator of the Environmental
Protection Agency (EPA) and any other
officer or employee of EPA to whom
authority has been delegated.
*
*
*
*
*
(c) Pesticide means any substance or
mixture of substances meeting the
definition in 7 U.S.C. 136(u) [Federal
Insecticide, Fungicide, and Rodenticide
Act, section 2(u)].
*
*
*
*
*
(k) Common Rule refers to the Federal
Policy for the Protection of Human
Subjects that was established in 1991 by
the Office of Science and Technology
Policy and codified in 1991 by EPA and
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
14 other federal departments and
agencies (see 56 FR 28003, June 18,
1991) and subsequently codified by
other Federal departments and agencies.
The Common Rule contains a widely
accepted set of standards for conducting
ethical research with human subjects,
together with a set of procedures
designed to ensure that the standards
are met. Once codified by a Federal
department or agency, the requirements
of the Common Rule apply to research
conducted or sponsored by that Federal
department or agency. EPA’s
codification of the Common Rule
currently appears in 40 CFR part 26,
subpart A.
§ 26.1111
[Amended]
4. In § 26.1111, remove from
paragraph (a)(4) the phrase ‘‘or the
subject’s legally authorized
representative’’.
5. In § 26.1116, revise the
introductory text of the section to read
as follows:
§ 26.1116 General requirements for
informed consent.
No investigator may involve a human
being as a subject in research covered by
this subpart unless the investigator has
obtained the legally effective informed
consent of the subject. An investigator
must seek such consent only under
circumstances that provide the
prospective subject sufficient
opportunity to consider whether or not
to participate and that minimize the
possibility of coercion or undue
influence. The information that is given
to the subject must be in language
understandable to the subject. No
informed consent, whether oral or
written, may include any exculpatory
language through which the subject is
made to waive or appear to waive any
of the subject’s legal rights, or releases
or appears to release the investigator,
the sponsor, the institution or its agents
from liability for negligence.
*
*
*
*
*
6. Revise § 26.1117 to read as follows:
§ 26.1117
consent.
Documentation of informed
(a) Informed consent must be
documented by the use of a written
consent form approved by the IRB and
signed by the subject. A copy shall be
given to the subject.
(b) The consent form may be either of
the following:
(1) A written consent document that
embodies the elements of informed
consent required by § 26.1116. This
form may be read to the subject, but in
any event, the investigator must give the
PO 00000
Frm 00035
Fmt 4702
Sfmt 4702
5753
subject adequate opportunity to read it
before it is signed; or
(2) A short form written consent
document stating that the elements of
informed consent required by § 26.1116
have been presented orally to the
subject. When this method is used, there
must be a witness to the oral
presentation. Also, the IRB shall
approve a written summary of what is
to be said to the subject. Only the short
form itself is to be signed by the subject.
However, the witness must sign both the
short form and a copy of the summary,
and the person actually obtaining
consent must sign a copy of the
summary. A copy of the summary must
be given to the subject, in addition to a
copy of the short form.
7. Revise the heading for subpart L to
read as follows:
Subpart L—Prohibition of Third-Party
Research Involving Intentional
Exposure to a Pesticide of Human
Subjects Who Are Children or
Pregnant or Nursing Women
8. Revise § 26.1201 to read as follows:
§ 26.1201
apply?
To what does this subpart
This subpart applies to any research
subject to subpart K of this part.
9. Revise § 26.1301 to read as follows:
§ 26.1301
apply?
To what does this subpart
This subpart applies to any person
who submits to EPA after [effective date
of final rule] either of the following:
(a) A report containing the results of
any human research for consideration in
connection with an action that may be
performed by EPA under FIFRA (7
U.S.C. 136–136y) or section 408 of
FFDCA (21 U.S.C. 346a).
(b) A report containing the results of
any human research on or with a
pesticide for consideration in
connection with any action that may be
performed by EPA under any regulatory
statute administered by EPA.
§ 26.1302
[Amended]
10. In § 26.1302 remove the word
‘‘shall’’.
§ 26.1502
[Amended]
11. Amend § 26.1502 as follows:
a. In the first sentence of paragraph (a)
remove the period after the phrase
‘‘during an inspection.’’ and add in its
place a comma; and
b. In the second sentence of paragraph
(a) remove the phrase ‘‘The agency’’ and
add in its place ‘‘EPA’’.
c. In the last sentence of the
introductory text of paragraph (b)
remove the phrase ‘‘the Agency’’ and add
in its place ‘‘EPA’’.
E:\FR\FM\02FEP1.SGM
02FEP1
5754
§ 26.1505
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
[Amended]
12. In § 26.1505 remove from the last
sentence, the phrase ‘‘§ 26.1502(c)’’ and
add in its place ‘‘§ 26.1502(b)(4)’’.
§ 26.1507
[Amended]
13. In § 26.1507 remove from the last
sentence, the phrase ‘‘The Agency’’ and
add in its place ‘‘EPA’’.
§§ 26.1601 through 26.1603 [Redesignated
as §§ 26.1603 through 26.1605]
14. Amend subpart P by redesignating
§§ 26.1601 through 26.1603 as
§§ 26.1603 through 26.1605.
15. Add new §§ 26.1601 and 26.1602
to read as follows:
§ 26.1601
apply?
To what does this subpart
This subpart applies to both of the
following:
(a) Reviews by EPA and by the
Human Studies Review Board of
proposals to conduct new research
subject to 40 CFR 26.1125.
(b) Reviews by EPA after [effective
date of the final rule] and, to the extent
required by § 26.1604, by the Human
Studies Review Board of reports of
completed research subject to 40 CFR
26.1701.
§ 26.1602
Definitions.
The definitions in § 26.1102 apply to
this subpart as well.
16. Amend newly redesignated
§ 26.1603 as follows:
a. Remove paragraphs (a) and (e).
b. Redesignate paragraphs (b) through
(d) as (e) through (g).
c. Add new paragraphs (a), (b), (c), (d),
and (h) to read as follows.
mstockstill on DSKH9S0YB1PROD with PROPOSALS
§ 26.1603 EPA review of proposed human
research.
(a) EPA must review all proposals for
new human research submitted under
§ 26.1125 in a timely manner.
(b) In reviewing proposals for new
human research submitted under
§ 26.1125, the EPA Administrator must
consider and make determinations
regarding the proposed research,
including:
(1) Whether the research would be
likely to produce data that address an
important scientific or policy question
that cannot be resolved on the basis of
animal data or human observational
research.
(2) Whether the proposed research is
designed in accordance with current
scientific standards and practices to:
(i) Address the research question.
(ii) Include representative study
populations for the endpoint in
question.
(iii) Have adequate statistical power to
detect appropriate effects.
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
(3) Whether the investigator proposes
to conduct the research in accordance
with recognized good research practices,
including, when appropriate, good
clinical practice guidelines and
monitoring for the safety of subjects.
(c) In reviewing proposals for new
research submitted under § 26.1125, the
EPA Administrator must consider and
make determinations regarding ethical
aspects of the proposed research,
including:
(1) Whether adequate information is
available from prior animal studies or
from other sources to assess the
potential risks to subjects in the
proposed research.
(2) Whether the research proposal
adequately identifies anticipated risks to
human subjects and their likelihood of
occurrence, minimizes identified risks
to human subjects, and identifies likely
benefits of the research and their
distribution.
(3) Whether the proposed research
presents an acceptable balance of risks
and benefits. In making this
determination for research intended to
reduce the interspecies uncertainty
factor in a pesticide risk assessment, the
Administrator must consider
Recommendation 4–1 in the 2004
Report from the National Research
Council of the National Academy of
Sciences (NAS), entitled ‘‘Intentional
Human Dosing Studies for EPA
Regulatory Purposes: Scientific and
Ethical Issues.’’
(4) Whether subject selection will be
equitable.
(5) Whether subjects’ participation
would follow free and fully informed
consent.
(6) Whether an appropriately
constituted IRB or its foreign equivalent
has approved the proposed research.
(7) If any person from a vulnerable
population may become a subject in the
proposed research, whether there is a
convincing justification for selection of
such a person, and whether measures
taken to protect such human subjects
are adequate.
(8) If any person with a condition that
would put them at increased risk for
adverse effects may become a subject in
the proposed research, whether there is
a convincing justification for selection
of such a person, and whether measures
taken to protect such human subjects
are adequate.
(9) Whether any proposed payments
to subjects are consistent with the
principles of justice and respect for
persons, and whether they are so high
as to constitute undue inducement or so
low as to be attractive only to
individuals who are socioeconomically
disadvantaged.
PO 00000
Frm 00036
Fmt 4702
Sfmt 4702
(10) Whether the sponsor or
investigator would provide needed
medical care for injuries incurred in the
proposed research, without cost to the
human subjects.
(d) With respect to any research or
any class of research, the EPA
Administrator may recommend
additional conditions which, in the
judgment of the EPA Administrator, are
necessary for the protection of human
subjects.
*
*
*
*
*
(h) EPA must provide the submitter of
the proposal copies of the EPA and
Human Studies Review Board reviews.
17. Amend newly redesignated
§ 26.1604 by revising paragraph (a) to
read as follows:
§ 26.1604 EPA review of completed human
research.
(a) When considering, under any
regulatory statute it administers, data
from completed research involving
intentional exposure of humans to a
pesticide, EPA must thoroughly review
the material submitted under § 26.1303,
if any, and other available, relevant
information and document its
conclusions regarding the scientific and
ethical conduct of the research.
*
*
*
*
*
18. Add §§ 26.1606 and 26.1607 to
read as follows:
§ 26.1606 Human Studies Review Board
review of proposed human research.
In commenting on proposals for new
research submitted to it by EPA, the
Human Studies Review Board must
consider the scientific merits and
ethical aspects of the proposed research,
including all elements listed in
§ 26.1603(b) and (c) and any additional
conditions recommended pursuant to
§ 26.1603(d).
§ 26.1607 Human Studies Review Board
review of completed human research.
In commenting on reports of
completed research submitted to it by
EPA, the Human Studies Review Board
must consider the scientific merits and
ethical aspects of the completed
research, and must apply the
appropriate standards in subpart Q of
this part.
19. Revise the heading for subpart Q
to read as follows:
Subpart Q—Standards for Assessing
Whether To Rely on the Results of
Human Research in EPA Actions
20. Revise §§ 26.1701 through 26.1705
to read as follows:
*
*
*
*
*
Sec.
26.1701
E:\FR\FM\02FEP1.SGM
To what does this subpart apply?
02FEP1
Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Proposed Rules
26.1702 Definitions.
26.1703 Prohibitions applying to all
research subject to this subpart.
26.1704 Prohibition of reliance on unethical
human research with non-pregnant, nonnursing adults which is not subject to
§ 26.1705.
26.1705 Prohibition of reliance on unethical
human research with non-pregnant, nonnursing adults initiated after April 7,
2006, and subject to subparts A through
L of this part, or the codification of the
Common Rule by another Federal
department or agency.
(b) Prohibition of reliance on research
subject to this subpart involving
intentional exposure of human subjects
who are pregnant women (and therefore
their fetuses), nursing women, or
children. Except as provided in
§ 26.1706, EPA must not rely on data
from any research subject to this subpart
involving intentional exposure of any
human subject who is a pregnant
woman (and therefore her fetus), a
nursing woman, or a child.
*
§ 26.1704 Prohibition of reliance on
unethical human research with nonpregnant, non-nursing adults which is not
subject to § 26.1705.
*
§ 26.1701
apply?
*
*
*
To what does this subpart
(a) For decisions under FIFRA (7
U.S.C. 136–136y) or section 408 of
FFDCA (21 U.S.C. 346a), this subpart
applies to research involving intentional
exposure of human subjects to any
substance.
(b) For decisions under any regulatory
statute administered by EPA other than
those statutes designated in paragraph
(a) of this section, this subpart applies
to research involving intentional
exposure of human subjects to a
pesticide.
§ 26.1702
Definitions.
The definitions in § 26.1102 and
§ 26.1202 apply to this subpart as well.
mstockstill on DSKH9S0YB1PROD with PROPOSALS
§ 26.1703 Prohibitions applying to all
research subject to this subpart.
(a) Prohibition of reliance on
scientifically invalid research. EPA
must not rely on data from research
subject to this subpart unless EPA
determines that the data are relevant to
a scientific or policy question important
for EPA decisionmaking, that the data
were derived in a manner that makes
them scientifically valid and reliable,
and that it is appropriate to use the data
for the purpose proposed by EPA. In
making such determinations, EPA must
consider:
(1) Whether the research was
designed and conducted in accordance
with appropriate scientific standards
and practices prevailing at the time the
research was conducted.
(2) The extent to which the research
subjects are representative of the
populations for the endpoint or
endpoints in question.
(3) The statistical power of the data to
support the scientific conclusion EPA
intends to draw from the data.
(4) In a study that reports only a No
Observed Effect Level (NOEL) or a No
Observed Adverse Effect Level
(NOAEL), whether a dose level in the
study gave rise to a biological effect,
thereby demonstrating that the study
had adequate sensitivity to detect an
effect of interest.
VerDate Mar<15>2010
16:04 Feb 01, 2011
Jkt 223001
(a) This section applies to research
subject to this subpart that is not subject
to § 26.1705.
(b) Except as provided in § 26.1706,
EPA must not rely on data from any
research subject to this section if there
is clear and convincing evidence that:
(1) The conduct of the research was
fundamentally unethical (e.g., the
research was intended to seriously harm
participants or failed to obtain informed
consent); or
(2) The conduct of the research was
deficient relative to the ethical
standards prevailing at the time the
research was conducted in a way that
placed participants at increased risk of
harm (based on knowledge available at
the time the study was conducted) or
impaired their informed consent.
(c) The prohibition in this section is
in addition to the prohibitions in
§ 26.1703.
§ 26.1705 Prohibition of reliance on
unethical human research with nonpregnant, non-nursing adults initiated after
April 7, 2006, and subject to subparts A
through L of this part, or the codification of
the Common Rule by another Federal
department or agency.
(a) This section applies to research
subject to this subpart, that:
(1) Was initiated after April 7, 2006.
(2) Was subject, at the time it was
conducted, either to subparts A through
L of this part, or to the codification of
the Common Rule by another Federal
department or agency.
(b) Except as provided in § 26.1706,
EPA must not rely on data from any
research subject to this section unless
EPA determines that the research was
conducted in substantial compliance
with either:
(1) All applicable provisions of
subparts A through L of this part, or the
codification of the Common Rule by
another Federal department or agency;
or
(2) If the research was conducted
outside the United States, with
procedures at least as protective of
PO 00000
Frm 00037
Fmt 4702
Sfmt 4702
5755
subjects as those in subparts A through
L of this part, or the codification of the
Common Rule by another Federal
department or agency.
(c) Except as provided in § 26.1706,
EPA must not rely on data from any
research subject to this section unless
EPA determines that the research was
conducted in substantial compliance
with either:
(1) A proposal that was found to be
acceptable under § 26.1603(c), and no
amendments to or deviations from that
proposal placed participants at
increased risk of harm (based on
knowledge available at the time the
study was conducted) or impaired their
informed consent. If EPA discovers that
the submitter of the proposal materially
misrepresented or knowingly omitted
information that would have altered the
outcome of EPA’s evaluation of the
proposal under § 26.1603(c), EPA must
not rely on that data.
(2) A proposal that would have been
found to be acceptable under
§ 26.1603(c), if it had been subject to
review under that section, and no
amendments to or deviations from that
proposal placed participants at
increased risk of harm (based on
knowledge available at the time the
study was conducted) or impaired their
informed consent.
(d) The prohibition in this section is
in addition to the prohibitions in
§ 26.1703.
§ 26.1706
[Amended]
21. In paragraph (d) of § 26.1706
remove the word ‘‘publishes’’ and add in
its place the phrase ‘‘has published’’.
[FR Doc. 2011–1629 Filed 2–1–11; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Parts 416, 418, 482, 483, 484,
485, 486, and 491
[CMS–3225–P]
RIN 0938–AP94
Medicare and Medicaid Programs;
Patient Notification of Right To Access
State Survey Agencies and Medicare
Beneficiary Notification of the Right To
Access Quality Improvement
Organizations
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Proposed rule.
AGENCY:
E:\FR\FM\02FEP1.SGM
02FEP1
Agencies
[Federal Register Volume 76, Number 22 (Wednesday, February 2, 2011)]
[Proposed Rules]
[Pages 5735-5755]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1629]
[[Page 5735]]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 26
[EPA-HQ-OPP-2010-0785; FRL-8862-7]
RIN 2070-AJ76
Revisions to EPA's Rule on Protections for Subjects in Human
Research Involving Pesticides
AGENCY: Environmental Protection Agency (EPA).
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: EPA proposes to amend the portions of its rules for the
protection of human subjects of research applying to third parties who
conduct or support research with pesticides involving intentional
exposure of human subjects and to persons who submit the results of
human research with pesticides to EPA. The proposed amendments would
broaden the applicability of the rules to cover human testing with
pesticides submitted to EPA under any regulatory statute it
administers. They would also disallow participation in third-party
pesticide studies by subjects who cannot consent for themselves.
Finally the proposed amendments would identify specific considerations
to be addressed in EPA science and ethics reviews of proposed and
completed human research with pesticides, drawn from the
recommendations of the National Academy of Sciences (NAS). In seeking
comments on these proposed amendments, EPA does not imply that the
current Federal Policy for the Protection of Human Subjects (the
``Common Rule''), which governs research with human subjects conducted
or supported by EPA and many other Federal departments and agencies, is
inadequate. Indeed, the amendments proposed here would make no changes
to the Common Rule or EPA's codification of the Common Rule. Rather,
EPA is proposing these amendments to other portions of its regulation
as a result of a settlement agreement, and is now seeking comment on
these proposed amendments. The settlement agreement makes clear that
EPA retains full discretion concerning what amendments are proposed,
and what, if any, amendments are finalized. Furthermore, no research
has been identified that is outside the scope of EPA's current rule,
but that would be within the scope of these proposed amendments. EPA
seeks comments on the need for and value of the proposed changes.
DATES: Comments must be received on or before April 4, 2011.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2010-0785, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket Facility's normal hours of operation (8:30
a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
Special arrangements should be made for deliveries of boxed
information. The Docket Facility telephone number is (703) 305-5805.
Instructions: Direct your comments to docket ID number EPA-HQ-OPP-
2010-0785. EPA's policy is that all comments received will be included
in the docket without change and may be made available on-line at
https://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through regulations.gov or e-
mail. The regulations.gov Web site is an ``anonymous access'' system,
which means EPA will not know your identity or contact information
unless you provide it in the body of your comment. If you send an e-
mail comment directly to EPA without going through regulations.gov,
your e-mail address will be automatically captured and included as part
of the comment that is placed in the docket and made available on the
Internet. If you submit an electronic comment, EPA recommends that you
include your name and other contact information in the body of your
comment and with any disk or CD-ROM you submit. If EPA cannot read your
comment due to technical difficulties and cannot contact you for
clarification, EPA may not be able to consider your comment. Electronic
files should avoid the use of special characters, any form of
encryption, and be free of any defects or viruses.
Docket: All documents in the docket are listed in the docket index
available at https://www.regulations.gov. Although listed in the index,
some information is not publicly available, e.g., CBI or other
information whose disclosure is restricted by statute. Certain other
material, such as copyrighted material, is not placed on the Internet
and will be publicly available only in hard copy form. Publicly
available docket materials are available either in the electronic
docket at https://www.regulations.gov, or, if only available in hard
copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac
Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The hours of
operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday
through Friday, excluding legal holidays. The Docket Facility telephone
number is (703) 305-5805.
FOR FURTHER INFORMATION CONTACT: Kelly Sherman, Immediate Office of the
Director (7501P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001; telephone number: (703) 305-8401; fax number: (703) 308-4776; e-
mail address: sherman.kelly@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you sponsor,
conduct, review, or submit to EPA research with pesticides involving
human subjects. Potentially affected entities may include, but are not
limited to:
Pesticide and other agricultural chemical manufacturers
(NAICS code 325320) who sponsor or conduct human research with
pesticides.
Other entities (NAICS code 541710) that sponsor or conduct
human research with pesticides, and Institutional Review Boards who
review human research with pesticides to ensure it meets applicable
standards of ethical conduct.
This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes are provided to assist you and others in determining whether this
action might apply to certain entities. If you have any questions
regarding the applicability of this action to a particular entity,
consult the person listed under FOR FURTHER INFORMATION CONTACT.
B. What should I consider as I prepare my comments for EPA?
1. Submitting CBI. Do not submit confidential business information
(CBI)
[[Page 5736]]
to EPA through regulations.gov or e-mail. Clearly mark the part or all
of the information that you claim to be CBI. For CBI information in a
disk or CD-ROM that you mail to EPA, mark the outside of the disk or
CD-ROM as CBI and then identify electronically within the disk or CD-
ROM the specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
2. Tips for preparing your comments. When submitting comments,
remember to:
a. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
b. Follow directions. The Agency may ask you to respond to specific
questions or organize comments by referencing a Code of Federal
Regulations (CFR) part or section number.
c. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
d. Describe any assumptions and provide any technical information
and/or data that you used.
e. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
f. Provide specific examples to illustrate your concerns and
suggest alternatives.
g. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
h. Make sure to submit your comments by the comment period deadline
identified.
II. Background
A. What would the proposed amendments do?
The proposed amendments would change the 2006 rule, published in
the Federal Register issue of February 6, 2006 (71 FR 6138) (FRL-7759-
8), subsequently amended on June 23, 2006 (71 FR 36171) (FRL-8071-6),
and codified at 40 CFR part 26, in the following substantive respects:
By broadening the applicability of 40 CFR part 26,
subparts K, L, M, and Q, so these subparts would apply not only to
research submitted to or considered by EPA under the pesticide laws,
but also to research involving a ``pesticide'' (as defined in the
Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) (7 U.S.C.
136(u)) which is submitted to or considered by EPA under any other
regulatory statute it administers.
By incorporating the definition of ``pesticide'' from
FIFRA, as a substance or mixture of substances intended for pesticidal
effect.
By deleting from 40 CFR part 26, subpart K, all references
to consent on behalf of a subject in research involving intentional
exposure to a pesticide by a subject's ``legally authorized
representative.''
By incorporating into 40 CFR part 26, subparts P and Q,
factors to be considered by EPA and the Human Studies Review Board
(HSRB) in their review of proposed and completed research, derived from
the recommendations of NAS in its 2004 Report to EPA, and from the
Nuremberg Code.
The amendments proposed here would make no changes to the Federal
Policy for the Protection of Human Subjects (the ``Common Rule''),
which governs research with human subjects conducted or supported by
EPA and many other Federal departments and agencies. EPA's codification
of the Common Rule appears as subpart A in 40 CFR part 26.
Subparts B, C, and D of 40 CFR part 26 would also be unchanged by
these proposed amendments. These subparts categorically prohibit any
EPA research involving intentional exposure to any substance of human
subjects who are children or pregnant or nursing women (40 CFR part 26,
subpart B), and provide extra protections for pregnant women and for
children who are the subjects of observational research conducted or
supported by EPA (40 CFR part 26, subparts C and D).
The proposed amendments would retain without substantive change the
core provisions of the 2006 rule applying to the conduct of human
pesticide research by third parties--i.e., research neither conducted
nor supported by EPA or another Common Rule Federal department or
agency. These substantively unchanged provisions:
Categorically prohibit new research involving intentional
exposure of pregnant or nursing women or of children to a pesticide (40
CFR part 26, subpart L).
Apply the provisions of the Common Rule to third-party
human research involving intentional exposure of non-pregnant, non-
nursing adults to a pesticide (40 CFR part 26, subpart K).
Require submission to EPA of proposals for new covered
research before it is initiated (40 CFR part 26, subpart K, Sec.
26.1125).
Require persons who submit to EPA reports of completed
human research on pesticides to document the ethical conduct of that
research (40 CFR part 26, subpart M).
Establish an independent HSRB to review and advise EPA
concerning both proposals for new human research involving intentional
exposure to a pesticide and reports of completed research on which EPA
proposes to rely in its actions (40 CFR part 26, subpart P).
The proposed amendments would make only minor editorial revisions
to 40 CFR part 26, subpart O, which defines administrative actions
available to EPA to address non-compliance with 40 CFR part 26,
subparts A through L.
The proposed amendments would retain the essential structure of 40
CFR part 26, subpart P, which defines the processes of EPA and HSRB
review of proposed and completed research. The amendments, however,
would also add substantial new clarifying language to 40 CFR part 26,
subpart P, as discussed in detail in Unit IV.C. of this document.
The proposed amendments would retain the essential structure of 40
CFR part 26, subpart Q, which defines the standards to be applied when
EPA proposes to rely on data from completed research involving
intentional exposure of human subjects to a pesticide. The amendments,
however, would also add substantial new clarifying language to 40 CFR
part 26, subpart Q, as discussed in detail in Unit IV.D. of this
document.
The proposed amendments would not change the provision in 40 CFR
part 26, subpart Q, forbidding EPA to rely on any otherwise
unacceptable research involving intentional exposure of human subjects
to a pesticide, except under extremely restrictive conditions. These
conditions require a public review by HSRB, an opportunity for public
comment, and a showing by EPA that to do so would result in a more
protective regulatory standard than could be justified without reliance
on the unethical research.
B. What is the agency's authority for taking this action?
The legal authority for the 2006 rule on human research is set
forth in the preamble to that final rule (71 FR 6138, February 6, 2006)
(FRL-7759-8). These proposed amendments to that rule rest upon the same
legal authority. In particular, the legal authority for expanding the
2006 rule to cover research involving the intentional exposure of a
human subject to a pesticide submitted under any EPA
[[Page 5737]]
regulatory statute is provided by section 201 of the Department of the
Interior, Environment, and Related Agencies Appropriations Act, 2006,
Public Law 109-54 (2006 Appropriations Act), and FIFRA.
The 2006 Appropriations Act directly mandates that EPA promulgate a
rule on ``third-party intentional dosing human toxicity studies for
pesticides * * *'' without limiting the rule to pesticide studies
submitted under FIFRA or section 408 of the Federal Food, Drug, and
Cosmetic Act (FFDCA) (21 U.S.C. 346a).
Additionally, under FIFRA, EPA has the authority to issue
regulations as to both unregistered and registered pesticides used in
research involving the intentional exposure of a human subject, whether
or not that research is conducted for submission under FIFRA. Section
3(a) of FIFRA authorizes EPA to regulate the distribution, sale, or use
of any unregistered pesticide in any State ``[t]o the extent necessary
to prevent unreasonable adverse effects on the environment'' (defined
at FIFRA section 2(bb), in pertinent part, as ``any unreasonable risk
to man or the environment, taking into account the economic, social,
and environmental costs and benefits of the use of any pesticide'').
EPA concludes that there would be an unreasonable risk to humans if
unregistered pesticides were used in research involving intentional
exposure of human subjects (or sold and distributed for such use) that
is not already covered by the Common Rule absent compliance with the
applicable rules in 40 CFR part 26, as proposed. The importance of
these rules to the protection of human subjects is demonstrated in the
2004 Report from the National Research Council of the NAS, entitled
``Intentional Human Dosing Studies for EPA Regulatory Purposes:
Scientific and Ethical Issues'' (2004 NAS Report) (https://www.national-academies.org).
Section 25(a) of FIFRA authorizes EPA to ``prescribe regulations to
carry out the provisions of [FIFRA].'' (7 U.S.C. 136w(a)). Regulations
protecting human subjects in research involving the intentional
exposure of human subjects to registered pesticides fall within that
purview. FIFRA provides that a pesticide may not be registered unless
use of the pesticide under its labeling will not cause unreasonable
risks to humans or the environment, that a pesticide may not be used
inconsistent with its label, and that a pesticide may not be used in
human testing unless the subjects are fully informed regarding the
nature, purpose, and physical and mental health consequences of the
testing and freely volunteer. (See 7 U.S.C. 136(bb), 136a(c)(5),
136j(a)(2)(G), 136j(a)(2)(P)). The 2006 rule and the amendments
proposed in this document ensure that these provisions regarding use of
registered pesticides in a manner that does not cause unreasonable risk
and full and free consent in human testing with pesticides are
effectuated.
III. EPA's Human Subjects Protection Rules
A. Overarching Principles
EPA is committed to relying on scientifically sound research that
is ethically conducted, and to transparency in its review processes and
decision-making. EPA issued the 2006 rule to further these commitments
and nothing in the amendments proposed in this document will change
that. These proposed amendments can be seen as increasing the
transparency of EPA's decision-making process by clarifying the scope
and applicability of the requirements in 40 CFR part 26, codifying the
scope and approach used in EPA's science and ethics reviews of human
research involving pesticides.
B. Appropriations Act of 2006
In August 2005, in the 2006 Appropriations Act, which appropriated
funds for EPA and other Federal departments and agencies for FY 2006,
Congress included at section 201 the following provision:
None of the funds made available by this Act may be used by the
Administrator of the Environmental Protection Agency to accept,
consider or rely on third-party intentional dosing human toxicity
studies for pesticides, or to conduct intentional dosing human
toxicity studies for pesticides until the Administrator issues a
final rulemaking on this subject. The Administrator shall allow for
a period of not less than 90 days for public comment on the Agency's
proposed rule before issuing a final rule. Such rule shall not
permit the use of pregnant women, infants or children as subjects;
shall be consistent with the principles proposed in the 2004 report
of the National Academy of Sciences on intentional human dosing and
the principles of the Nuremberg Code with respect to human
experimentation; and shall establish an independent Human Subjects
Review Board. The final rule shall be issued no later than 180 days
after enactment of this Act.
In response, EPA published a proposed rule in the Federal Register
issue of September 12, 2005 (70 FR 53838) (FRL-7728-2), accepted public
comment until December 12, 2005, and promulgated on February 6, 2006, a
final rule which took effect on April 7, 2006 (71 FR 6138) (FRL-7759-
8). The 2006 rule, as subsequently amended on June 23, 2006, to extend
special protections to nursing women as well (71 FR 36171) (FRL-8071-
6), is discussed in Unit III.E. and is now being further amended by
this proposed rule.
C. EPA's 2006 Rule
1. Summary of contents. The 2006 rule established a set of
protections for people participating as subjects in third-party human
research with pesticides. (In this context ``third-party'' research is
research neither conducted (``first-party'') nor supported (``second-
party'') by EPA or another Common Rule Federal department or agency.)
The 2006 rule bans all third-party research on pesticides involving
intentional exposure of children or of pregnant or nursing women. It
further forbids EPA itself to conduct or support any research involving
intentional exposure of pregnant or nursing women or of children to any
substance. EPA was required to promulgate the 2006 rule by the 2006
Appropriations Act.
The 2006 rule also extends the ethical protections in the Common
Rule to third-party studies of non-pregnant, non-nursing adult subjects
intentionally exposed to pesticides. The key provisions of the 2006
rule include:
Requiring pre-implementation submission to EPA of
protocols and related information about proposed research to ensure any
future studies meet high ethical standards.
Establishing an independent HSRB to obtain expert peer
review of both proposals for new research intended for submission to
EPA and reports of completed human research involving intentional
exposure on which EPA proposes to rely in an action taken under the
pesticide laws.
Prohibiting EPA from relying on the results of research in
its actions under the pesticide laws unless EPA determines that the
research meets acceptance standards derived from the recommendations in
the 2004 NAS Report.
2. Research with pesticides since promulgation of the 2006 rule.
Contrary to some predictions, the 2006 rule has not led to an upsurge
in human research with pesticides for submission to EPA under FIFRA or
FFDCA. Since promulgation of the 2006 rule EPA has received no
proposals at all for research on the toxicity of a pesticide to human
subjects, and has received significantly fewer than were projected
proposals for new research of other kinds (e.g., insect repellent
studies). In the analyses supporting the 2006 rule, EPA estimated 33
new intentional exposure studies would be submitted each year; in fact,
only 26 proposals for new research on pesticides for submission to EPA
under
[[Page 5738]]
FIFRA and FFDCA have been submitted over a span of approximately 5
years, or just over 5 per year.
3. Overview of HSRB reviews. EPA's experience in implementing the
2006 rule is critical to understanding the amendments proposed in this
document. The public meetings of HSRB have served as key milestones in
the implementation of the 2006 rule, and the implementation of the 2006
rule can be best characterized by summarizing what HSRB has been called
upon to review. HSRB met for the first time in April 2006, immediately
after the 2006 rule became effective, and has met 14 times since then,
most recently in October 2010. At these meetings, HSRB has reviewed
both reports of completed research and proposals for new research.
Specifically, HSRB has reviewed:
Completed reports of pre-2006 rule research reporting
toxic endpoints. These have included intentional exposure toxicity
tests initiated both before and after passage of the Food Quality
Protection Act (FQPA) in 1996, as well as therapeutic trials of
substances used both as drugs and as pesticides, reporting side effects
relevant to EPA pesticide risk assessments.
Proposals for and reports of new research involving
intentional exposure to materials used in the research as pesticides.
a. Pre-rule research reporting toxic endpoints. At its first two
meetings in April and May 2006, HSRB reviewed 28 reports of pre-rule
research conducted with 11 substances. At all its subsequent meetings
combined the Board has reviewed 14 more such reports. Half of these 42
reports were published; the rest were unpublished reports submitted
directly to EPA by pesticide companies. Of the 42 reports, 37 reported
non-therapeutic research, and 5 were published reports of therapeutic
trials that described side effects relevant to pesticide risk
assessments. We summarize the disposition of each of the 42 studies in
the following paragraphs, and additional details may be accessed in the
study specific reports available on the HSRB Web site at https://www.epa.gov/hsrb/index.htm.
Twenty-nine of the 37 non-therapeutic studies reviewed by HSRB were
initiated before the passage of FQPA in 1996; all reported toxic
endpoints. EPA conducted both science and ethic reviews of these
studies prior to submission of the studies to HSRB. EPA science
reviewers proposed to rely on 17 of these 29 studies. HSRB found 13 of
these 17 studies scientifically acceptable under the applicable
standards of the 2006 rule. EPA ethics reviewers found 5 of the 17
clearly acceptable, and deferred to HSRB concerning whether the
shortcomings noted in the conduct of the remaining 12 studies rose to
the level of ``significant'' deficiencies relative to prevailing
standards of ethical research conduct. HSRB found 15 of those 17
studies ethically acceptable under the applicable standards of the 2006
rule--Sec. 26.1703 and Sec. 26.1704. HSRB found 1 study ethically
unacceptable because of deficiencies in risk minimization procedures
that could have led to serious harm to subjects, and another
unacceptable because incomplete information provided to subjects
concerning previous studies seriously impaired their informed consent.
These 2 studies found by HSRB to be ethically unacceptable were among
those also found by HSRB to be scientifically unacceptable. EPA has not
subsequently relied on any studies deemed either scientifically or
ethically unacceptable by HSRB.
The 12 remaining pre-FQPA studies that EPA science reviewers had
proposed to reject concerned dichlorvos (DDVP). These reports on the
effects of dichlorvos had been submitted by the registrant to support a
proposal to reduce the inter-species uncertainty factor in EPA's DDVP
risk assessment. EPA reviewers found all 12 to be scientifically
unacceptable to reduce the inter-species factor since a dose response
could not be calculated due to numerous technical weaknesses. HSRB
concurred. Because the reported research was deemed scientifically
unacceptable for the proposed use, neither EPA nor HSRB explicitly
reviewed its ethical conduct. EPA has not relied on any of these 12
studies.
Turning to the 8 post-FQPA toxicity studies that EPA presented to
HSRB, we note that they were among a group of about 20 studies at the
center of controversy before promulgation of the 2006 rule. Other post-
FQPA human toxicity studies were deemed by EPA science reviewers to be
irrelevant to EPA's risk assessments, and have not been considered
further.
Of the eight relevant post-FQPA toxicity studies, EPA science
reviewers found six scientifically acceptable and proposed to rely on
them, found one more to be clearly scientifically unacceptable to set a
point of departure because no effect was measured from the single dose
level tested \1\, and deferred to HSRB with respect to the scientific
acceptability of the last one. HSRB concurred that the first six
studies were scientifically acceptable, and found both the others
unacceptable. EPA ethics reviewers found four of the eight studies
clearly acceptable, one clearly unacceptable, and deferred to HSRB's
judgment whether the shortcomings noted in the conduct of the remaining
three rose to the level of ``significant'' deficiencies relative to
prevailing standards of ethical conduct. HSRB found all but one of
these eight studies ethically acceptable under the applicable standards
in the 2006 rule. Studies found either scientifically or ethically
unacceptable by HSRB have not subsequently been relied on by EPA in any
actions.
---------------------------------------------------------------------------
\1\ For more details on this finding, see the study report
available on the HSRD Web site at https://www.epa.gov/hsrb/index.htm.
---------------------------------------------------------------------------
EPA also proposed to rely on five published reports of therapeutic
trials of materials that may be used as either drugs or as pesticide
active ingredients. In these studies the reported toxic endpoints
relevant to EPA pesticide risk assessments were not the main objective
of the research, they were reported side effects of treatment when a
test material (which is sometimes used as a pesticide) was administered
as a medication. HSRB concurred with the EPA science reviews that these
four studies were scientifically unacceptable, but found one study
scientifically unacceptable for the purpose EPA proposed. EPA ethics
reviewers and HSRB both found all five of these studies to be ethically
acceptable under the standards of the 2006 rule.
In summary, EPA and HSRB worked through the backlog of pre-rule
studies of pesticide toxicity awaiting review when the 2006 rule was
promulgated. EPA and HSRB agreed about the acceptability of these
studies in most cases; when there was disagreement, EPA has accepted
HSRB recommendation. Some pre-rule studies that met the scientific and
ethical standards defined in the 2006 rule have been relied upon by EPA
in actions under the pesticide laws, although EPA has not relied on any
studies found unacceptable by HSRB. Meanwhile, as EPA completed the
reassessment of tolerances mandated by FQPA, it found human toxicity
testing to be relevant to only a handful of those assessments.
b. New research involving intentional exposure of human subjects.
In addition to reviewing pre-2006 rule research, HSRB has reviewed
proposals for new research involving intentional exposure of human
subjects. EPA developed a detailed ``framework'' for its reviews of
these proposals (see the HSRB Web site at https://www.epa.gov/hsrb/index.htm). This framework has been used to guide all subsequent EPA
reviews, and has
[[Page 5739]]
been refined in detail to incorporate suggestions from HSRB. A
completed framework addressing concerns identified in the 2004 NAS
Report and subsequently by HSRB has been attached to each EPA review of
a proposal for new research under the 2006 rule.
Since promulgation of the 2006 rule EPA has received no proposals
at all for new research concerning pesticide toxicity or metabolism in
human subjects. All submitted proposals for new research have been for
research involving intentional exposure of human subjects to registered
pesticides used for pesticidal purposes in the research itself. This
has included proposals for research to measure the duration of
effectiveness of skin-applied repellents intended to keep mosquitoes,
ticks, and other pests away from the treated skin of human subjects,
and for research monitoring occupational exposure of pesticide handlers
as they mix, load, or apply pesticides in a variety of agricultural and
non-agricultural use scenarios.
Close scrutiny by both EPA and HSRB of proposals for new repellent
performance testing and worker exposure monitoring studies has led to
steady and substantial improvement both in the scientific design of
these studies and in their provision for ethical treatment of subjects.
These reviews have led to some delays in field research costly to the
study sponsors, but the sponsors and investigators proposing these
studies have learned how to design and execute them efficiently and in
full compliance with the standards of the 2006 rule. These studies
provide essential information about repellent performance and worker
exposure that is not available except from well designed, ethically
conducted research involving intentional exposure of human subjects to
pesticides.
i. Repellent performance studies. Repellent performance studies
using human subjects have been required by EPA for many years to
support registration of pesticide products bearing claims to keep
mosquitoes, ticks, or other pests away from treated human skin. Since
2006, HSRB has reviewed proposals for 13 new repellent performance
studies testing a total of 29 repellent formulations. EPA and HSRB
identified enough scientific and ethical deficiencies in their initial
review of the first 2 such proposals that a second review was required.
After they were revised and resubmitted, both proposals were reviewed
favorably by EPA and HSRB. All subsequent proposals for new repellent
performance studies have been found acceptable, with identified needed
refinements, upon their first review by EPA and HSRB.
Five of the 13 proposals have been for laboratory research with
caged insects or ticks reared in the laboratory and known to be
disease-free. The remaining studies have been for field studies of
repellency against wild populations of insects. Three of the 13 studies
have measured the duration of tick repellency in the laboratory--2 of
them concurrently testing repellency to 2 species of ticks. Two more
have measured the duration of repellency to biting flies--1 in the
laboratory with laboratory-reared stable flies, and another in the
field measuring repellency against black flies. The remaining 8 studies
have measured the duration of repellency against mosquitoes--7 of them
in the field, in areas where previous monitoring has not found evidence
of infection of potential disease vectors among the wild insects
present, and 1 in the laboratory with laboratory-reared, pathogen-free
mosquitoes.
In all these cases, HSRB has concurred with the EPA science and
ethics reviews, in some cases recommending further refinements. One
proposal was abandoned by its sponsor after a favorable HSRB review; 11
more have been amended consistent with EPA and HSRB recommendations and
executed. Reports of these 11 have been submitted to EPA and reviewed
by EPA and HSRB. The most recent proposal is expected to be executed in
the field in 2011.
In one case EPA and HSRB found the execution of a completed field
mosquito repellency test to have been non-compliant with 40 CFR part
26, subparts A-L. This study protocol was subsequently revised and re-
executed; the report of the re-executed study was found acceptable by
EPA and HSRB.
Reports of all the other ten completed repellent performance
studies were found both scientifically and ethically acceptable by EPA
and HSRB as first submitted.
ii. Studies of occupational exposure of pesticide handlers. All
other proposals for new research submitted to EPA since promulgation of
the 2006 rule have been for research monitoring exposure of
professional pesticide handlers as they mix, load, or apply pesticides
in well-defined agricultural and non-agricultural use scenarios. In
such research, experienced workers performing their usual tasks are
typically monitored at different sites, representing the range of
variation in use practices, equipment, and other factors likely to
affect exposure. Potential dermal exposure of the workers is measured
by analyzing residues in special ``long underwear'' worn under their
normal work clothing, and by rinsing their hands, face and neck.
Potential inhalation exposure is measured with a portable air sampler
worn in the breathing zone of each worker. This type of research has
also long been required by EPA to support its assessments of worker
risk.
Five proposals for field monitoring of worker exposure submitted to
EPA by an industry consortium were presented to HSRB in June 2006.
These proposals were from the Agricultural Handlers Exposure Task Force
(AHETF). HSRB review was highly critical, and called for substantially
greater information from both the consortium and from EPA concerning
the overall design of the research program, the statistical design of
the proposed studies, the uses to which the resulting data would be put
by EPA, and many other aspects of the proposed research. All five of
these proposals were subsequently withdrawn so that HSRB criticisms
could be addressed prior to resubmission.
Since that initial review, the overall designs of the umbrella
monitoring programs of AHETF and the designs from the Antimicrobial
Exposure Assessment Task Force (AEATF II) have been fully documented
and presented to HSRB. HSRB continues to review the design of
individual monitoring studies, but the soundness of the overall
approaches of both the AEATF II and AHETF programs have been
established.
Monitoring studies for four antimicrobial exposure scenarios
submitted by the AEATF II have been presented to HSRB and approved with
suggestions for refinements by both EPA and HSRB. These four scenarios
involve common methods of application of antimicrobial pesticide
products, including mopping, wiping down surfaces with a pre-soaked
ready-to-use wipe, spraying surfaces with a pump spray and wiping them
down with a cloth, and spraying surfaces with an aerosol product that
does not need to be wiped off. For each scenario, monitoring of workers
at three distinctive locations was proposed. After amendment of the
protocols consistent with EPA and HSRB recommendations, the first three
of these four studies have been executed; the first complete scenario
report was submitted to EPA and reviewed by HSRB in October 2010. The
remaining reports of completed AEATF II exposure research were
submitted to EPA in the fall of 2010, and are scheduled for
presentation to HSRB in early 2011.
Monitoring studies for four agricultural exposure scenarios
[[Page 5740]]
submitted by the AHETF have been presented to HSRB and approved, again
with suggestions for refinements by both EPA and HSRB. These scenarios
involve application of liquid pesticides to trellis and orchard crops
using ``air-blast'' spray equipment with closed cabs, application of
liquid pesticides using air-blast spray equipment with open cabs,
mixing and loading pesticides sold in water-soluble packaging into a
wide variety of application equipment, and application of herbicides to
rights-of-way. Each of these scenarios calls for monitoring workers in
five different regions of the United States, working with different
kinds of equipment and crops. The first two of these four studies have
been executed; the first complete scenario report was submitted to EPA
and reviewed by HSRB in October 2010. Reports of the remaining research
scenarios will be submitted to EPA and presented to HSRB in 2011.
D. Legal Challenge to the 2006 Rule
In early 2006, the Natural Resources Defense Council, Inc.,
Pesticide Action Network North American, Pineros y Campesinos Unido Del
Noroeste, Physicians for Social Responsibility--San Francisco, Farm
Labor Organizing Committee, ALF-CIO, and Migrant Clinicians Network
petitioned for review of the 2006 rule in the United States Court of
Appeals for the Second Circuit (Second Circuit Court of Appeals). (NRDC
v. EPA, No. 06-0820-ag (2d Cir.)). The Petitioners argued that the 2006
rule violated the 2006 Appropriations Act because it did not bar all
pesticide research with pregnant women and children, was inconsistent
with the 2004 NAS Report, and was inconsistent with the Nuremburg Code.
The following paragraphs describe the Petitioner's arguments in greater
detail.
1. Inadequate bar against research with pregnant women and
children. Petitioners argued that the scope of the 2006 rule's ban on
research with pregnant women and children was unlawfully narrow because
it was limited to studies intended for submission to EPA under FIFRA or
FFDCA--the pesticide regulatory laws EPA administers. Petitioners
argued that Congress's direction to EPA in the Appropriations Act to
``not permit the use of pregnant women, infants, or children as
subjects'' in ``intentional dosing human toxicity studies for
pesticides'' did not allow EPA to distinguish between studies
originally intended for publication and those intended for submission
to EPA, or between studies with pesticides conducted for consideration
under FIFRA or FFDCA and those conducted for consideration under the
Safe Drinking Water Act or any other regulatory statute. Petitioners
argued that EPA's 2006 rule violated the plain language of the 2006
Appropriations Act on this point.
2. Inconsistency with the 2004 NAS Report. The 2006 Appropriations
Act required EPA's rule to be consistent with the principles proposed
in the 2004 NAS Report. Petitioners argued that in citing the
``principles'' of the 2004 NAS Report, Congress was referring to the 17
recommendations in that report. Petitioners further argued that the
2006 rule was inconsistent with several specific recommendations in the
2004 NAS Report.
First, Petitioners argued that the 2006 rule did not incorporate
Recommendations 3-1 and 5-1 from the 2004 NAS Report, which recommend
factors to be considered in the scientific evaluation of human
research, including that such studies should have ``adequate
statistical power'' and involve ``representative populations for the
endpoint in question.''
Second, Petitioners argued that the 2006 rule did not incorporate
Recommendations 4-1 and 4-2 from the 2004 NAS Report, which suggest
ethical considerations relevant to evaluation of human studies.
Third, Petitioners argued that by adding qualifying language to the
acceptance standard for pre-rule research suggested in Recommendation
5-7 from the 2004 NAS Report, EPA made it inconsistent with the 2004
NAS Report. Petitioners argued that EPA's addition of the word
``significantly'' to the recommended acceptance standard, which permits
EPA to rely on research not ``significantly'' deficient relative to
prevailing standards, made the criterion in the 2006 rule unlawfully
inconsistent with the recommendations in the 2004 NAS Report.
Finally, Petitioners argued that the 2006 rule unlawfully failed to
require provision of medical care for study participants, as suggested
by Recommendation 5-5 from the 2004 NAS Report.
3. Inconsistency with the Nuremberg Code. The 2006 Appropriations
Act also required EPA's rule to be consistent with the principles in
the Nuremberg Code pertaining to human experimentation. Petitioners
argued that the 2006 rule was inconsistent with several principles in
the Nuremburg Code.
First, Petitioners argued that although the Nuremberg Code
specifies that consent must be given by the human subject, the 2006
rule permits consent to be given in certain situations by a legally
authorized representative of the subject.
Second, Petitioners argued that the 2006 rule was inconsistent with
the Nuremberg Code principle that a test subject ``should have
sufficient knowledge and comprehension of the elements of the subject
matter involved as to enable him to make an understanding and
enlightened decision.'' Petitioners argued that the 2006 rule consent
requirements were inadequate to ensure fully informed consent in the
context of research involving pesticides.
Third, Petitioners argued that the 2006 rule failed to address
adequately the Nuremberg Code principle that a subject must be ``so
situated as to be able to exercise free power of choice, without the
intervention of any element of force, fraud, deceit, duress, over-
reaching, or other ulterior form of constraint or coercion.''
Petitioners argued that the requirement of the 2006 rule that consent
should only be sought in circumstances that ``minimize the possibility
of coercion or undue influence'' did not address the potential for
fraud, deceit, over-reaching, or constraint. Petitioners asserted that
constraint was a particular problem when prisoners are used as subjects
in human studies, and the 2006 rule did not specifically address
research with prisoners.
Fourth, Petitioners argued that the 2006 rule was inconsistent with
the Nuremberg Code because it did not explicitly impose the Nuremburg
Code's requirement that human studies be ``designed and based on the
results of animal experimentation.''
Finally, Petitioners argued that the 2006 rule was inconsistent
with the Nuremberg Code principle that human testing ``should be such
as to yield fruitful results * * * unprocurable by other methods or
means of study, and not random and unnecessary in nature.'' Petitioners
argued that the 2006 rule requires no inquiry into whether human
testing is necessary given other methods of research.
E. Settlement of the Litigation
After briefing and argument, but before a decision was rendered by
the Second Circuit Court of Appeals, EPA and Petitioners began
negotiations to settle the litigation. In the settlement agreement
finalized on November 3, 2010, EPA agreed to conduct notice-and-comment
rulemaking on the issue of whether the 2006 rule should be amended. EPA
also agreed to propose, at a minimum, amendments to the 2006 rule that
are substantially consistent with language negotiated between the
[[Page 5741]]
parties and attached to the settlement agreement as Exhibit A. This
agreement, including Exhibit A, is available in the docket for this
action as described under ADDRESSES.
The settlement agreement further provides that EPA will propose the
negotiated amendments no later than January 18, 2011, and that EPA will
take final action on the amendments no later than December 18, 2011.
The settlement agreement, however, makes clear that EPA retains full
discretion concerning what amendments are proposed, and what, if any,
amendments are finalized.
Although the wording of the amendments proposed in this document
differs in a few details of construction and wording, they are
substantially consistent with the regulatory language negotiated with
Petitioners, and EPA considers these amendments to address the
Petitioners' major arguments outlined in Unit III.D. Specifically:
The proposed amendments would retain the scope of the 2006
rule to cover research submitted to EPA under FIFRA or FFDCA, and
extend that scope to cover as well research involving intentional
exposure to a pesticide, intended for submission to EPA under any other
regulatory statute administered by EPA.
The proposed amendments incorporate language from each of
the recommendations from the 2004 NAS Report cited by Petitioners in
their challenge to the 2006 rule, as well as other pertinent
recommendations from the 2004 NAS Report.
The proposed amendments address Petitioners' arguments
concerning the Nuremberg Code by dropping from 40 CFR part 26, subpart
K, all provisions for consent by a representative, and by requiring EPA
to consider whether subjects gave their ``free and fully informed
consent'' to participate in a study, whether the design of proposed new
human research takes into account the knowledge gained in earlier
animal testing, and whether proposed new human research is necessary.
Although these proposed amendments emerged from a settlement
agreement, EPA believes that proposing these amendments is consistent
with the language and purposes of the applicable statutes and because
they further the 2006 rule's goal of ensuring that EPA does not rely on
research involving intentional exposure of human subjects to pesticides
that is not ethically conducted or that is not scientifically sound.
EPA believes that many of the changes proposed in this document are
codifications of the manner in which EPA and HSRB have interpreted and
implemented the 2006 rule, but welcomes comment on these
interpretations. EPA will fully re-evaluate the appropriateness of the
proposed amendments in light of all comments received in response to
this proposed rule before making a final determination. In particular,
EPA seeks comment on the relative merits of the proposed changes
compared to retaining the current scope and content (i.e., current
wording) of the 2006 rule.
IV. Proposed Amendments, Rationale, and Request for Comment
This unit provides a description of each proposed change, the
rationale for the proposed change, and the anticipated effects of each
change relative to the current regulatory text (i.e., the 2006 rule).
EPA specifically requests comment on each of these proposed changes, as
well as on the changes in the aggregate. In particular, EPA asks for
comment on its conclusions regarding the effect of these proposed
changes, including the effect of these proposed changes on the volume
of studies covered by the rule, the likely statutes under which studies
may be submitted, and the impact on activities covered by those other
statutes, relative to the scope of the 2006 rule.
A. Redefining the Scope and Applicability of 40 CFR Part 26, Subparts
K, L, M, P, and O
1. Summary of proposed changes. EPA is proposing amendments that
would modify the scope and applicability of several subparts of the
2006 rule. The proposed changes would modify the criteria defining the
types of research covered by 40 CFR part 26, subparts K, L, and M--most
notably the criteria relating to the intentions of the sponsor or
investigator in conducting the research or the intentions of the person
submitting the research to EPA.
The specific changes proposed to the scope and applicability
sections of 40 CFR part 26, subparts K, L, M, P, and Q, are explained
here. Although EPA does not propose to change the text of the 2006 rule
defining the scope of 40 CFR part 26, subpart O, concerning
``Administrative Actions for Noncompliance,'' the scope of that subpart
would change nonetheless, because its applicability depends on the
scope provisions in other subparts that EPA is proposing to change.
More specifically, these changes alter the scope as follows: instead of
covering substances under FIFRA, the proposed amendments would cover
pesticides under all statutes.
In general, the proposed amendments would shift the focus from
whether the research on the substance was intended for EPA's
consideration and use under the pesticide laws, FIFRA and FFDCA, to
whether the research was conducted with a pesticide and was intended
for EPA's consideration and use in connection with an action under any
regulatory statute administered by EPA. The proposed amendments also
would add a new section to 40 CFR part 26, subpart P, defining its
scope and would change the scope and applicability of 40 CFR part 26,
subpart Q, to parallel the changes in 40 CFR part 26, subpart K.
2. Summary of anticipated effects. Although almost all studies with
pesticides are conducted and submitted to EPA for consideration under
FIFRA or FFDCA, it is possible that some pesticide studies may be
considered by EPA only under other regulatory authorities and not be
considered under FIFRA and FFDCA. If studies involving intentional
exposure of humans to a pesticide are submitted or considered under
other EPA regulatory statutes, with the proposed amendment, such
studies would be subject to the same requirements that would have
applied had they been submitted or considered under FIFRA or FFDCA. In
proposing these amendments, EPA finds that these changes in scope are
consistent with the focus in the 2006 Appropriations Act on intentional
dosing human toxicity studies with pesticides.
In sum, EPA does not believe that the several changes to the
``scope'' sections of 40 CFR part 26, subparts K and L--Sec. 26.1101
and Sec. 26.1201--and a new definition of ``pesticide'' at Sec.
26.1102(c), that expand the range of human research to which these two
subparts apply, will result in a significant increase in the number of
studies reviewed under the rule. However, EPA recognizes that this is a
possibility and requests comment on whether these proposed changes are
clear about which studies would fall under the scope of the rule. EPA
knows of no third-party research involving intentional exposure of a
human subject to a pesticide that has ever been proposed, conducted, or
submitted to EPA under regulatory authorities other than the pesticide
laws. The proposed expansion of the scope of these subparts, however,
would mean that any such studies that are proposed, conducted, or
submitted to EPA will be governed by the same standards as pesticide
studies submitted under FIFRA or FFDCA section 408.
3. 40 CFR part 26, subparts K and L--basic ethical requirements and
prohibitions applying to third-party research involving intentional
exposure of human subjects to a pesticide.
[[Page 5742]]
a. Current rule. Subpart K of 40 CFR part 26 extends the basic
protections of the Common Rule to subjects in certain third-party human
research; subpart L of 40 CFR part 26 forbids new third-party research
involving intentional exposure of children or of pregnant or nursing
women. In the 2006 rule these two subparts apply to ``research with a
human subject'' which meets four criteria. First, it was initiated
after April 7, 2006 (the effective date of the 2006 rule). Second, it
is ``research involving intentional exposure of a human subject'' as
defined at Sec. 26.1102(i). Third, it was conducted or supported by a
``person'' as defined at Sec. 26.1102(j). Fourth, it was intended by
any person conducting or supporting the research to be submitted to
EPA, or to be held for later inspection by EPA, under the pesticide
laws (FIFRA or FFDCA).
The two cited definitions are critical to understanding the scope
and applicability of subparts K and L of 40 CFR part 26. ``Research
involving intentional exposure of a human subject,'' is defined at
Sec. 26.1102(i) as ``a study of a substance in which the exposure to
the substance experienced by a human subject participating in the study
would not have occurred but for the human subject's participation in
the study.'' In applying this definition, EPA considers whether a test
subject would have experienced equivalent exposure to a test material
had the subject not participated in the research. If not, the research
is deemed to involve intentional exposure of the subject. Notably this
definition encompasses all classes of test substances--not only
pesticides.
A ``person'' is defined at Sec. 26.1102(j) to have the same
meaning as in FIFRA section 2(s) (7 U.S.C. 136(s)), except that it
excludes Federal agencies subject to the Common Rule and any person
when performing research supported by a Common Rule Federal department
or agency. This exclusion is appropriate because that research is
covered by the Common Rule, which provides necessary and appropriate
protections for the research subjects. Thus, research already covered
by the standards of the Common Rule is not also subject to subparts K
and L. These subparts, in short, apply only to ``third-party
research''--research that is neither conducted (``first-party'') nor
supported (``second-party'') by EPA or another Common Rule Federal
department or agency.
Finally, Sec. 26.1101(g) explains how EPA will approach
determination of the intent of sponsors or investigators to submit
research to EPA under the pesticide laws, or hold it for inspection by
EPA under the pesticide laws.
b. Proposed amendments, rationale, and anticipated effect. The
amendments proposed in this document would not change the definitions
of ``research involving intentional exposure of a human subject'' or of
``person.'' They would add a new definition of ``pesticide'' at Sec.
26.1102(c), and would modify the applicability provisions in Sec.
26.1101, as explained later in this Unit of the document.
The first of the four criteria for application of 40 CFR part 26,
subpart K, will change to incorporate the effective date of a final
rule amending the 2006 rule. EPA believes it would be inappropriate to
apply these proposed amendments retroactively. For example, if post-
2006 research newly covered by an amended rule as proposed in this
document were submitted to EPA, its acceptability should not be judged
by its compliance with a rule promulgated after it was conducted. Until
the 2006 rule is amended by a final rule, its provisions continue to
apply fully to new research. Hence no sponsor or investigator subject
to the 2006 rule would be relieved by the change in the effective date
of any obligation to comply with 40 CFR part 26, subparts K and L, for
research initiated between April 7, 2006, and the effective date of any
subsequent amendments.
The proposal would modify the second of the four criteria so that
40 CFR part 26, subparts K and L, would apply to research involving
intentional exposure of a human subject ``to a pesticide'' when the
research is intended for submission to EPA under any regulatory statute
other than FIFRA or FFDCA. The definition of ``research involving
intentional exposure of a human subject'' would not change, nor would
the applicability of these subparts to all new third-party research
involving intentional exposure of human subjects which is intended for
submission to EPA under FIFRA or FFDCA.
In determining whether research involves intentional exposure to a
pesticide, EPA will focus, as does the FIFRA definition of a
``pesticide,'' on the intended use of the substance. EPA expects that
application of this standard will nearly always be straightforward.
However, EPA recognizes that there may be cases where making such a
determination may not be as straightforward. EPA will apply this
criterion as follows.
Initially, EPA will examine the study on its face. If the study
states that it involves the testing of a pesticide, or if the tested
substance is used for pesticidal effect in the study, as it is in
insect repellent efficacy testing or in monitoring exposure of
pesticide applicators, there can be little question that the study
involves exposure to a pesticide. If on the other hand the study
reports testing of another type of substance, such as an industrial
chemical, waste product, or air pollutant, then absent compelling
evidence to the contrary, EPA will not treat the study as involving
exposure to a pesticide.
If it is not clear from the face of the study whether it involves
exposure to a pesticide, EPA will look to other objective factors to
determine whether a substance is being tested as a pesticide. Intent to
test a substance as a pesticide could be indicated by evidence that the
testing was conducted or supported by an entity regulated under FIFRA
or section 408 of FFDCA; the testing was conducted for the purpose of
attaining a FIFRA registration or FFDCA tolerance; there are not
significant commercial uses for the substance other than as a
pesticide; or human exposure to the substance occurs primarily from its
use as a pesticide. Absent any such evidence, EPA will generally treat
the study as not involving exposure to a pesticide.
EPA expects that in most cases, the question of whether the study
involves exposure to a pesticide will be quickly resolvable without
looking to other objective factors such as the four identified in the
previous paragraph. EPA believes that this would be true even for
multiple-use substances that may be used as a pesticide and may also
result in human exposure from other commercial uses or as a result of
deposition in the environment as a waste product.
A good example of how EPA will determine if studies on multi-use
substances are studies on a pesticide is presented by sulfur dioxide
(SO2)--a registered pesticide active ingredient used as a
fungicide in grape culture, and also a common air pollutant. Thousands
of tons of SO2 are released yearly into the atmosphere by
burning of coal and other fossil fuels. In promulgating National
Ambient Air Quality Standards (NAAQS) for SO2 under the
Clean Air Act (CAA) in 2010, EPA relied on numerous human studies
involving intentional exposure of subjects to SO2. Most of
these studies on their face indicate clearly that they tested
SO2 as an industrial air pollutant and not as a pesticide.
The few that do not expressly state they tested SO2 as an
air pollutant are, nonetheless, easily classified as not involving
exposure to a pesticide, because the testing was not conducted
[[Page 5743]]
or sponsored by a pesticide registrant, the studies do not indicate
they were performed in support of FIFRA registration, and there are
clearly other major sources of human exposure to SO2 in
addition to whatever pesticide exposure occurs. Thus, these studies
would not come within the scope of the 2006 rule if the scope is
modified as proposed.
EPA specifically requests comment on the implications of this
change for the volume of studies that may need to be reviewed under
such a proposed amendment.
The amendments proposed in this document would not change the
applicability of 40 CFR part 26, subparts K and L, to ``persons'' or
the definition of that term at Sec. 26.1102(j). Thus the third of the
four criteria would not be affected by these proposed amendments.
The fourth criterion would be broadened by the amendments proposed
in this document beyond the scope of the 2006 rule. The 2006 rule
applies to research with any substance, conducted with intent to submit
its results to EPA under FIFRA or FFDCA; as proposed here, the rule
would apply as well to research with a pesticide, conducted with intent
to submit its results to EPA ``for consideration in connection with any
action that may be performed under any regulatory statute administered
by EPA'' other than FIFRA or FFDCA.
The new element in this fourth criterion, putting aside the
proposed amendment to refer to ``pesticides,'' is the reference to
actions taken ``under any regulatory statute administered by EPA.''
Research intended for submission under FIFRA or FFDCA is covered by the
2006 rule and would continue to be covered under proposed Sec.
26.1101(a)(1). Proposed Sec. 26.1101(a)(2) would broaden the scope of
subparts K and L of 40 CFR part 26 to apply as well to research
involving intentional exposure of a human subject to a pesticide which
is intended for submission to EPA for consideration in connection with
any action that may be performed under any regulatory statute other
than FIFRA or FFDCA. Such submission could be made under CAA, the Safe
Drinking Water Act (SDWA), the Clean Water Act (CWA), the Resource
Conservation and Recovery Act (RCRA), the Comprehensive Environmental
Response, Compensation and Liability Act (CERCLA, or the Superfund
law), or other similar statutes. EPA specifically seeks comment on the
scope of this proposed change (i.e., the frequency with which it might
be triggered, including other statutes to which the proposed change
would apply) and the implications of the proposed changes on the
activities governed by those other regulations. EPA seeks comment on
the relative merits of this change compared to retaining the current
scope of the 2006 rule. As noted, EPA does not expect that these
wording changes will result in any substantive changes to the number or
manner in which studies are currently reviewed.
As an example, EPA's Office of Water has, in the past, set Maximum
Contaminant Levels (MCLs) under the SDWA with pesticides found in
drinking water. Under the proposed amendment to the scope of 40 CFR
part 26, subpart K, any new third-party study involving intentional
exposure of a human to a pesticide, and intended for submission to the
Office of Water for consideration in setting a MCL, would now be
subject to 40 CFR part 26, subpart K, including the requirement of
Sec. 26.1125 for submission of the proposal for prior review by EPA
and HSRB. EPA would note that this is a theoretical example in that it
is unaware of any such study having been submitted with regard to a
MCL.
EPA actions not taken under the authority of regulatory statutes
would not satisfy this fourth criterion. For example, an EPA comment on
another Federal department's or agency's Environmental Impact Statement
would not constitute an action taken under a regulatory statute, and
research intended for submission solely for consideration in such a
context would not be subject to 40 CFR part 26, subparts K and L.
EPA interprets the word ``action'' in this context broadly,
embracing both regulatory a